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Background: Infants of mothers who smoked (S) or substance misused (SM) during 
pregnancy have an increased risk of sudden infant death syndrome (SIDS). 
Hypotheses: Infants of SM and S mothers will have poorer ventilatory responsiveness to 
hypercarbia and hypoxia and reduced chemoreceptor sensitivity compared to controls 
Impairment of ventilatory responsiveness and chemoreceptor sensitivity will be greater in the 
infants of mothers who both substance abuse and smoke compared to those whose mothers 
only smoke  
Methods: Three groups were recruited: 
1. Infants of mothers with a history of substance misuse during pregnancy (SM infants) 
2. Infants of mothers with a history of smoking during pregnancy (S infants). 
3. Infants of mothers who neither smoked nor misused substances during pregnancy 
(Controls). 
Ventilatory responses to hypercarbia and hypoxia were assessed in the newborn period and at 
6-12 weeks of age  
Results: In the newborn period both the SM and S infants had a lower ventilatory response to 
2% and 4% CO2 than the controls. The ventilatory response to CO2 was lower in the SM 
infants compared to the S infants. In response to hypoxic challenge in the newborn period, 
SM infants had a greater magnitude of decline in minute volume than the S infants and the 
controls.  In addition, the rate of decline in minute volume was greater in the SM infants and 
the S infants compared to the controls. At 6-12 weeks of age S and SM infants had a 
dampened ventilatory response to hypercarbia and a greater magnitude of decline in minute 
volume in response to hypoxia compared to controls. Dampening of the ventilatory response 
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1 Introduction  
1.1 Background  
 
1.1.1 Historical perspective of Sudden Infant Death (SIDS) 
 
The sudden, tragic death of sleeping babies has been a feature of history for over 2000 
years.  "Overlaying" or the accidental suffocation of an infant by an adult who rolled on 
the baby while sleeping was, for centuries, thought to be the only reasonable explanation 
for an apparently healthy infant going peacefully to sleep and never waking up again. In 
ancient Egypt, a mother who was judged to be responsible for doing this was sentenced to 
hold the dead infant for three days and nights. The first known medical textbook written 
during the second century A.D. by the Greek physician Soranus of Ephesus instructs 
mothers and wet-nurses never to sleep with infants in case they should accidentally fall 
asleep on the baby and somehow suffocate them.  References to "overlaying" existed 
throughout the centuries. In 1291 in Germany there was a dictum-forbidding mothers to 
take children under 3 years of age into their beds. In the 14
th
 century in England, 
overlaying of one’s infant was considered a sin and punishments by the church were 
handed to mothers if overlaying occurred.  Later on during the 16
th
 century in Italy, 
penalties were given to unwed mothers whose infants suffocated in bed. The “Arcuccio”, 
a wooden framework with arches of iron was described in “The Art of Nursing”, London 
in 1733. It was placed between the husband and wife to prevent the child being overlaid 
(1895). In the 19
th
 century, there was a transition of punishment for infanticide from 
ecclesiastical to secular authority with civil and coroner’s courts beginning to investigate 
cases of overlaying. 
A more humanitarian attitude towards mothers whose infant had died suddenly and the 
mother would have faced prosecution followed the thymic theory by Morgagni in 1773. 
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He suggested that the gland  impinged on the trachea cutting off the airway or  the  blood  
supply  to  the   head  resulting  in  adverse  stimulation  of nerves   controlling  
respiration  and  thereby  causing suffocation.. The thymic theory also contributed to the 
ill-conceived concept of thymic irradiation in United States from 1926-1947.  Nineteenth-
century doctors naturally tried to explain scientifically the sudden deaths of babies, and 
one of the first such explanations was that the infant suffered from some sort of 
respiratory event. By the beginning of the twentieth century, sleep apnea was considered 
a cause. By the 1930s, the role of infection was being considered and by the 1940s, most 
American mothers were no longer taking their children to bed with them for fear of 
accidentally smothering them. 
 
1.1.2 Definition of Sudden Infant Death Syndrome (SIDS)  
 
Sudden Infant Death (SIDS) was first described over six decades ago. The original 
emphasis was on clinical history alone. Werne and Garrow in 1953 referred to SIDS as 
‘sudden apparently unexplained death during infancy’. (Garrow and Werne, 1953, Werne 
and Garrow, 1953) Adelson and Kinney in 1956 reported their cases as ‘sudden and 
unexpected death in infancy and childhood’.(Adelson and Kinney, 1956). They noted that 
these deaths occurred in ‘a child who was thought to be in good health or whose terminal 
illness appeared to be so mild that the possibility of a fatal outcome was not anticipated’. 
The definition of SIDS has undergone considerable changes since its original description.  
The requirement for autopsy was first emphasised by Beckwith in 1973: ‘the sudden 
death of any infant or young child which is unexpected by history and in which a 
thorough post-mortem examination fails to demonstrate an adequate cause of death 
(Beckwith, 1973). In 1991 that definition was revised by the National Institute of Child 
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Health and Human Development, restricting the cases to less than one year of age, and 
including examination of the death scene as part of the definition: ‘The sudden death of 
an infant under one year of age which remains unexplained after a thorough case 
investigation, including performance of a complete autopsy, examination of the death 
scene, and review of the clinical history’ (Willinger et al., 1991) 
The most recent revision of the definition of SIDS occurred in 2004, often referred to as 
the San Diego definition, which incorporated the apparent association with sleep and 
emphasised evaluating the circumstances of death: ‘the sudden unexpected death of an 
infant less than one year of age, with onset of the fatal episode apparently occurring 
during sleep, that remains unexplained after a thorough investigation, including 
performance of a complete autopsy and review of the circumstances of death and the 
clinical history’ (Krous et al., 2004) 
  
1.1.3  Incidence of Sudden Infant Death Syndrome (SIDS) 
 
Sudden Infant Death remains the leading cause of death in the post neonatal period in the 
developed world (Blair et al., 2006b). Since the ‘Back to Sleep’ campaign in 1991, the 
number of SIDS deaths has fallen by 75% in England and Wales (Health Statistics Quarterly 
winter 2004.Office for National Statistics-The Stationery Office). The SIDS rate in England 
and Wales was 1.4 deaths per 1000 live births in 1991. In 2012, there were 221 deaths from 
SIDS in England and Wales. This is the equivalent of 0.3 deaths per 1,000 live births and 
accounted for 8% of all infant deaths occurring in 2012. Eight out of ten unexplained infant 
deaths occurred in the post-neonatal period (between 28 days and one year) and 64% were 
boys. The rate of unexplained infant death was three times higher among low birthweight 
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babies (less than 2,500g) than babies with a normal birthweight (2,500g and over). 
(Unexplained Death in Infancy: England and Wales 2012- Office for National Statistics). 
Among the industrialized nations, Japan has the lowest reported SIDS rate (0.09 case per 
1000 infants), New Zealand has the highest rate (0.80 per 1000), and the United States has an 
intermediate rate (0.57 per 1000) (Moon et al., 2007a) . A striking discrepancy exists among 
racial and ethnic groups that have been studied; with SIDS rates that are two to seven times 
the national averages among native Americans (Iyasu et al., 2002) and blacks (Hauck et al., 
2003) in the United States; among Maoris in New Zealand (Mitchell et al., 1994) and among 
aboriginal Australians (Ford and Nelson, 1995) . SIDS data from 13 predominantly 
industrialized countries, (Hauck and Tanabe, 2008) showed that the majority of countries had 
a major decrease in SIDS rates from 1990 to 2005 , with the largest decreases occurring 
before 2000 (Hauck and Tanabe, 2008). These decreases ranged from 40% in Argentina to 






















                                          
 
The precise pathophysiology of SIDS is not clearly defined, but is widely thought to be 
multifactorial.  The risk model was first proposed by Froggatt et al. in 1971: ‘The age range 
represents a period of enhanced physiological vulnerability in which some critical 
combination of extrinsic (e.g., infection and sleep) and intrinsic (not yet unequivocally 
identified) factors can prove lethal’ (Froggatt et al., 1971).  
 
The fatal triangle was proposed in 1993 by Rognum and Saugstad (Rognum and Saugstad, 
1993). They proposed the interplay of three factors: (i) a vulnerable phase in the development 
of the central nervous system and the immune system in the first months after birth, (ii) 
predisposing factors, such as brainstem astrogliosis or genetic make-up, and (iii) a trigger 
event such as overstimulation of the immune system. 
 
The ‘Triple Risk Model’ describes SIDS as an event that results from the intersection of three 
overlapping factors: (i) a vulnerable infant, (ii) a critical development period in homeostatic 
Figure  1.1 Triple Risk Model (Filiano and Kinney, 1994) 
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control, and (iii) an exogenous stressor (Filiano and Kinney, 1994) (Figure1.1). The 
vulnerability of the infant (e.g. premature birth) lies latent until the infant enters a critical 
period of development (usually one to six months) and is exposed to an exogenous stressor 
(e.g. prone sleeping or hypercarbia). 
Studies have shown that some SIDS victims have a subtle underlying immaturity or 
abnormality of the central nervous system (CNS) making them vulnerable to various 
physiological challenges, including being positioned prone.  Filiano & Kinney (Filiano and 
Kinney, 1992a) showed evidence of arcuate nucleus hypoplasia in SIDS victims. This is an 
area thought to be an integrative site for chemosensitivity, ventilatory control, autonomic 
function and arousal (Filiano and Kinney, 1992a). Kinney’s group postulated that SIDS is 
caused by an underlying brainstem abnormality in neural networks that mediate protective 
responses to asphyxia (Kinney et al., 2009). They have reported deficiencies related to the 
neurotransmitters serotonin and γ-aminobutyric acid in infants who died of SIDS (Kinney and 
Thach, 2009). A reduction of serotonin receptor binding has also been found in SIDS victims 
in four other regions of the ventral medulla believed to be involved in the homeostatic 
response (Panigrahy et al., 2000).   
 
 Kinney and Thach postulated the following lethal sequence in the pathophysiology of SIDS: 
rebreathing in face-down position, face-covered in supine position or obstructive apnea 
occurring during sleep being life-threatening event that causes severe asphyxia, brain 
hypoperfusion or both (Kinney and Thach, 2009). The vulnerable infant does not arouse and 
turn his head in response to this asphyxia resulting in rebreathing or inability to recover from 
apnea. Progressive asphyxia leads to loss of consciousness and rapid-onset hypoxic-coma. 
Extreme bradycardia and hypoxic gasping begins. Autoresuscitation fails with onset of 
ineffectual gasping resulting in death.  Subsequently Randall et al. have compared SIDS 
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cases in circumstances consistent with asphyxia and infants dying suddenly without obvious 
asphyxia-generating circumstances. There were, however, no differences in the mean 
neurobiochemical parameters (Randall et al., 2013). Brain-stem abnormalities were 
associated with both asphyxia-generating and non-asphyxia-generating conditions. They 
concluded that safe sleep messages are essential for all infants 
 
1.1.5 Risk factors of SIDS     
                    
Risk factors for SIDS can be divided into extrinsic and intrinsic categories (Paterson et al., 
2006). Extrinsic risk factors are physical stressors that would place a vulnerable infant at risk 
for asphyxia or other homeostatic derangement. Such extrinsic factors include prone and 
side-sleeping positions, bedclothes that cover the head, sleeping on sofas or other soft 
furniture in which the infant could become wedged, a high ambient temperature in the 
sleeping environment, soft bedding, and bed sharing (Mitchell et al., 1994, Willinger et al., 
1994) (Iyasu et al., 2002) (Hauck et al., 2003)  (Kemp et al., 2000)  (Ponsonby et al., 1993). 
 Although the incidence of a prone sleeping position is currently 20% or less (Hauck and 
Tanabe, 2008) (Corwin et al., 2003), 30 to 50% of infants with SIDS are still found in the 
prone position (Mitchell et al., 2008). Approximately 50% of sudden infant deaths occur 
when infants are sharing a bed, sofa, or sofa chair with another person (Hauck et al., 2003). 
The prone sleeping position and a soft mattress are associated with an increase by a factor of 
20 in the risk of SIDS, suggesting the additive risk for these two factors (Ponsonby et al., 
1993). However, there are arguments in favour of bed sharing, which include facilitation of 
breast-feeding and nighttime bonding, behaviours that are beneficial to an infant's wellbeing 
(McKenna et al., 2007). Approximately 10% of SIDS cases occur in infants who sleep in a 
supine position and do not share a bed and whose face is not covered by bedclothes (Beal, 
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2000). This finding reinforces the points that such risk factors are not causative and that the 
causes of SIDS are multifactorial. 
 
In addition to extrinsic risk factors related to external events around the time of death, 
intrinsic factors are postulated to affect the underlying vulnerability of the infant to SIDS. 
Intrinsic risk factors can be subdivided into developmental factors, such as prematurity 
(Horne, 2006), and genetic factors, such as familial SIDS (i.e., a recurrence of SIDS in 
subsequent siblings) (Oyen et al., 1996, Hunt, 2001) , male sex (by a 2:1 ratio), and race or 
ethnic group (Hauck et al., 2003). 
Certain genetic polymorphisms have been found to increase the risk of SIDS (Opdal and 
Rognum, 2004, Hunt, 2001) (Weese-Mayer et al., 2007) (Hunt, 2005). Polymorphisms 
associated with SIDS have been reported in a variety of genes involved in autonomic 
function, neurotransmission, energy metabolism, and response to infection (Hunt, 2001) 
(Weese-Mayer et al., 2007) (Hunt, 2005). In addition, the vulnerable infant's response to 
environmental factors may actually reflect aberrant intrinsic responses. For that reason, 
events and environmental conditions extrinsic to the infant, such as poverty (Beal, 2000) 
(Ford and Nelson, 1995)  (Malloy and Hoffman, 1995) (Blair et al., 2006a), adverse prenatal 
exposures to certain substances (e.g., cigarette smoke and alcohol or illicit drugs) (Moon et 
al., 2007a) (Iyasu et al., 2002) (Blair et al., 2006b) (Blair et al., 1996)  and postnatal exposure 
to cigarette smoke, may trigger intrinsic responses in the vulnerable infant. For instance, 
prenatal exposures to alcohol and cigarette smoke have a direct effect on neurotransmitter 






Table 1.1  Risk factors associated with an increased risk of SIDS 
 
 
 Male gender 
 Ethnicity  
 Sociodemographic factors:  
 
            Low maternal age and education 
            High birth order,  
            Single motherhood,  
            Low maternal & paternal education 
            Maternal and paternal unemployment 
 Prematurity and low birth weight 
 Substance misuse  
 Smoking 
 Sleep environment & practices 
Use of Pillows and soft bedding- 
 Overheating 
 Prone positioning 
 Lack of prenatal care 
 Genetic predisposition  
 
Recently, changes have been identified in the demographic characteristics of infants who 
succumb to SIDS. In the United Kingdom, for example, the proportion of SIDS deaths 
occurring in term infants has decreased, whereas the proportion in preterm infants has 
increased from 12% to 34% (P<0.001) (Blair et al., 2006b). Furthermore, the proportion of 
SIDS deaths occurring in families living in poverty has increased from 47% to 74% (P = 
0.003), and the proportion of SIDS deaths in infants of mothers who smoked during 
pregnancy has increased from 57% to 87% (P = 0.004) (Blair et al., 2006b). 
The delineation of risk factors has been crucial in establishing the biologic basis of disparities 
in the incidence of SIDS among racial and ethnic groups (Iyasu et al., 2002, Hauck et al., 
2003, Mitchell et al., 1992). Although high SIDS rates among American blacks and native 
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Americans, Maoris, and aboriginal Australians may reflect factors that are independent of 
economic levels, poverty is associated with higher rates of maternal alcohol use and smoking 
during pregnancy, prematurity and bed sharing (due to a lack of space and funds for cribs) 
(Mitchell et al., 1992) (Iyasu et al., 2002, Hauck and Tanabe, 2008).  
1.1.6 Age at death from SIDS 
 
SIDS deaths tend to occur under six months of age with a peak incidence between two and 
three months of age (Peterson et al., 1979); (MacArthur and Bartholomew, 1987); (Adams et 
al., 1990). It has been noted that racial origin, birth weight and maternal smoking have an 
effect on the mean age at death. Black infants were noted to die at a younger age compared to 
non-black infants in the NICHD study (Hoffman and Hillman, 1992). Very low birth weight 
infants died at six weeks older postnatal age in the California Birth Defects Monitoring 
Program (Grether and Schulman, 1989). Others, however, have demonstrated that 
prematurely born infants die of SIDS at a 4 to 6 weeks younger compared to the term infants 
(Malloy and Hoffman, 1995). Infants of smoking mothers died at a younger postnatal age in 
the Swedish cohort, the incidence of SIDS in the infants born to smoking mothers peaked at 
five to eight weeks compared to the peak age of nine to thirteen weeks in infants of non-
smoking mothers (Haglund and Cnattingius, 1990). These facts emphasise that premature 








1.2 Smoking and Sudden Infant Death  
1.2.1         Prevalence of smoking during pregnancy  
 
To estimate the prevalence of maternal smoking during pregnancy, self-reported data from 
birth registers were often used due to their accessibility (Mattsson et al., 2016). Self-
reporting, however, carries a risk of underreporting due to the stigma surrounding smoking in 
pregnancy, leading to biases. Indeed, a reliable measure of smoking exposure is key for 
planning future studies concerning health effects of tobacco use (England et al., 2007) 
Cotinine (the primary metabolite of nicotine), passes readily through the placenta and can be 
measured both in maternal and umbilical cord serum. Umbilical cord cotinine is considered 
the gold standard of measuring fetal tobacco exposure (Pichini et al., 2000). Studies looking 
at the level of agreement between self-reporting of smoking and biochemical screening for 
smoking during pregnancy have provided conflicting results. Although some have found a 
correlation between self-reported smoking and biomarker measures (George et al., 2006, 
Kvalvik et al., 2012), others have demonstrated a significant underreporting using the self-
reporting method as opposed to biochemical screening (Lindqvist et al., 2002, Webb et al., 
2003, Parna et al., 2005). A validation study comparing self-reports with serum cotinine of a 
national sample found that 23% of pregnant smokers and 10% of non-pregnant smokers did 
not disclose their smoking habits (Dietz et al., 2011). A study from Sweden found that the 
agreement between mothers’ self-reported smoking habits during pregnancy and their levels 
of serum cotinine was high, as was the transfer of cotinine from mother to fetus (Mattsson et 
al., 2016) 
 
Smoking At Time Of Delivery (SATOD) dataset and the Infant Feeding Survey (IFS) are the 
two main data sources that provide information on the prevalence of smoking during 
pregnancy in England (Health and Social Care Information Centre). SATOD data have been 
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collected from primary care trusts quarterly by the Health and Social Care Information 
Centre. In order to collect these data, health professionals in maternity units are required to 
record the smoking status of every woman at the time of delivery. The IFS is a UK wide 
retrospective survey that is undertaken every five years and includes information on self-
reported maternal smoking behaviour, involving a sample of women who have registered live 
births during a particular time period. Both of these data sources showed that reported rates of 
smoking in pregnancy in England have fallen over time. The most recent SATOD dataset 
showed that 11.4 per cent of mothers were recorded as smokers at the time of delivery for 
2014/15, which is lower than 2013/14 (12.0%) and continues the steady year-on-year decline 
in the percentage of women smoking at the time of delivery from 15.1 per cent in 2006/07 
(Statistics on Women’s Smoking Status at Time of Delivery: England, Quarter 4, April 2014 
to March 2015 - http://www.hscic.gov.uk/). The IFS data in 2010 reflects similar results. 
Around a quarter of mothers (26%) in the UK smoked in the 12 months before or during their 
pregnancy, which was reduced from 33% in 2005. Of mothers who smoked before or during 
their pregnancy, over half (54%) gave up at some point before the birth (Infant Feeding 
Survey 2010-The Information Centre for Health & Social Care http://www.hscic.gov.uk/). 
Twelve per cent of mothers continued to smoke throughout their pregnancy, down from 17% 
in 2005. This translates into over 83,000 infants born to smoking mothers each year. In some 
areas of England these rates are much higher. For example, in the North East, 20% of women 
were recorded as smoking at the time of delivery (Infant Feeding Survey 2010-The 
Information Centre for Health & Social Care http://www.hscic.gov.uk/). The 2010 IFS also 
showed that smoking rates not only vary by region but also by age and social group. Pregnant 
women from unskilled occupation groups are five times more likely to smoke than 
professionals, and teenagers in England are six times more likely to smoke than older 
mothers. Although both sources show that smoking prevalence among pregnant women is 
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falling, it is important to note that they are both likely to underestimate the true number of 
pregnant smokers in England. This is due to women under-reporting smoking behaviour 
(Shipton et al., 2009) and incomplete or incorrect completion of data collection forms. In 
addition to this, the prevalence may be under-estimated further due to the fact that women 
who miscarry, or have a stillbirth, are not included in the data sets; missing an important 
category of women where smoking may have contributed to their pregnancy loss. 
  
In the United States of America, the Pregnancy Risk Assessment Monitoring System 
(PRAMS) provided data on smoking before, during, and after pregnancy from 40 sites during 
2000–2010  (Tong et al., 2013). There were moderate, but significant decreases in the 
prevalence of women smoking while pregnant (from 13.3% to 12.3%) and after delivery 
(from 18.6% to 17.2%) in a subgroup of sites. Several sites had significant reductions in 
smoking prevalence around the time of pregnancy. During 2000–2010, in three sites, the 
prevalence decreased for smoking before, during, and after pregnancy, and in eight sites , the 
prevalence decreased for one or two of the measures (before, during, or after pregnancy). A 
comparable decline in maternal smoking was also reported in national data from Sweden and 
Denmark (Cnattingius, 2004).  
 
1.2.2  SIDS and Maternal Smoking  
 
Since the “Back to Sleep” campaign, cigarette smoke exposure is the leading independent 
risk factor for the occurrence of SIDS (Mitchell et al., 1997, Moon et al., 2007b).   The first 
report of the association of maternal smoking and SIDS was published by Steele et al (Steele 
and Langworth, 1966). An odds ratio of 2.4 was obtained which was not significantly 
reduced by allowance for low birth weight (Steele and Langworth, 1966).This was followed 
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by a series of case- control and cohort studies showing an increased risk of SIDS in relation 
to both prenatal and postnatal maternal smoking. Schoendorf and colleagues showed that 
both in-utero and ex-utero passive exposure to smoking increased the risk of SIDS by two to 
three fold (Schoendorf and Kiely, 1992). According to both the National Institute of Child 
and Human Development study (Hoffman et al., 1988) and a prospective Australian study in 
Tasmania, (McGlashan, 1989) maternal smoking was more common amongst mothers of 
SIDS victims (OR=3.8, and OR =3.0, respectively). A dose dependent effect of exposure to 
tobacco smoking and the risk of SIDS was demonstrated in the New Zealand cot death study 
that included 162 SIDS deaths (Mitchell et al., 1991). The odds ratio was 1.87 when exposure 
was less than 10 cigarettes per day, which increased to 2.64 and 5.06 when infants were 
exposed to 10-19 cigarettes and more than 20 cigarettes per day respectively (Mitchell et al., 
1991).   A case control study undertaken in Scotland showed that exposure to cigarette smoke 
increased the SIDS risk much more if the mother or both parents smoked as compared to 
paternal smoking alone or if neither parent smoked in the household (Brooke et al., 1997). 
Similarly, the risk of SIDS in mothers who smoked in pregnancy was significantly higher 
(OR 4.1; 95% CI 3-5.7) in the Nordic epidemiologic SIDS study (Oyen et al., 1997). 
MacDorman and colleagues (MacDorman et al., 1997) compared the association between 
SIDS and smoking between Sweden and United States and concluded that the strong 
association between SIDS and smoking persisted  after adjustment for maternal age, birth 
order and infant birth weight. They also demonstrated a dose-response relationship with the 
odds ratios increasing from 1.6 to 2.5 for mothers who smoked between 1 and 9 cigarettes per 
day during pregnancy to 2.3 to 3.8 for mothers who smoked more than 10 cigarettes per day 
(MacDorman et al., 1997).   In a population based case control study involving three regions 
of the United Kingdom, maternal smoking increased the risk of SIDS (OR 2.1). A 
combination of paternal smoking/ postnatal exposure to an in-utero maternal smoking further 
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increased the risk of SIDS (OR 2.5 and 2.9 respectively) (Blair et al., 1996). The first 
systematic review on the association of SIDS and maternal smoking was published by 
Anderson and Cook in 1997. The review included 39 case control and cohort studies 
(Anderson and Cook, 1997) . The unadjusted pooled odds ratio for prenatal maternal smoking 
was 2.77 (95% CI 2.45 to 3.13). After adjustment for a variety of confounders the pooled 
odds ratio was reduced to 2.08 (95% CI 1.83 to 2.38) and was similar in cohort and case-
control studies. The OR for postnatal smoking after controlling for prenatal maternal smoking 
was 1.94 (95% CI 1.55 to 2.43).  
 
 A study from Sweden utilizing the Swedish Medical Birth Registry following the back to 
sleep intervention campaign showed that the adjusted OR for maternal smoking and SIDS 
was 4.11 (95% CI: 2.72, 6.21) (Chong et al., 2004). In a retrospective cohort study utilizing 
the Colorado birth registry over the time period of the Back to Sleep campaign, “smoking” 
exposed infants were 1.9 times (95% CI 1.6 to 2.3) more likely to die of SIDS (Anderson et 
al., 2005). In a study from the Netherlands with 142 cases of SIDS that occurred after the 
parental education on sleeping position  and 2,841 controls, postnatal smoking was identified 
as an important risk factor for SIDS (OR one parent=2.5 [1.2, 5.0]; both parents=5.77 [2.2, 
15.5]; maternal=2.7 [1.0, 6.4]; paternal=2.4 [1.3, 4.5] (Liebrechts-Akkerman et al., 2011). A 
recent meta-analysis by (Zhang and Wang, 2013) of 35 case control studies on the association 
between  maternal smoking and SIDS risk between 1990 to 2011 provided similar results. 
Both prenatal and postnatal maternal smoking, were associated with a significantly increased 
risk of SIDS (OR = 2.25, 95% CI = 2.03–2.50 for prenatal maternal smoking, and OR = 1.97, 
95% CI = 1.77–2.19 for postnatal maternal smoking analysis, respectively). Infants co-
sleeping with smoking mothers also had a significantly increased risk of SIDS (OR = 1.86, 
95% CI = 1.28–2.69) (Zhang and Wang, 2013) 
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 A number of studies have reported that maternal smoking modifies the effect of some risk 
factors for SIDS. A study from Germany found that preterm birth, low birthweight and low 
number of antenatal visits did not increase the risk of SIDS among infants of maternal non-
smokers, but were important risk factors for infants of maternal smokers (Schellscheidt et al., 
1997). For example, compared with normal birthweight (2500+ g) infants, low birthweight 
(<2500 g) was associated with an increased risk of SIDS in infants of mothers who smoked 
(RR = 2.62), but not in infants of non-smoking mothers (RR = 1.17). Alternatively, the 
relative risk of SIDS associated with maternal smoking was 7.96 for infants less than 2500 g 
and 3.56 for infants more than 2500 g. Meta-analysis of six studies showed that bed sharing 
was a major risk factor for SIDS if the mother was a smoker (OR = 2.06, 95% CI = 1.70, 
2.50), but was associated with only a slightly increased risk if the mother was a non-smoker 
(OR = 1.42, 95%CI = 1.12, 1.79) (Scragg and Mitchell, 1998). 
 
1.2.3 Pathophysiology of SIDS associated with smoking  
 
Prenatal smoking may cause morphological placental changes that lead to chronic fetal 
hypoxic stress and abnormal lung and brain development (Hofhuis et al., 2003). Nicotine is a 
powerful stimulant of cholinergic neurons and has been postulated to act upon nicotinic 
acetylcholine receptors either centrally (Kinney et al., 1993) or peripherally (Holgert et al., 
1995). Postnatal exposure to cigarette smoke may trigger intrinsic responses in the vulnerable 
infant and have a direct effect on neurotransmitter systems that are critical to homeostatic 
control in the developing human brain (Kinney and Thach, 2009).  Measurements of nicotine 
and its metabolites in babies diagnosed as dying from SIDS indicate that significant exposure 
has occurred around the time of death (Milerad et al., 1994, Milerad et al., 1998). High levels 
of cotinine in the pericardial fluid of SIDS victims who were co-sleeping and had focal organ 
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lesions in the liver and the heart could reflect previous hypoxic ischemic insult (Rajs et al., 
1997). Delayed myelination of the central nervous system particularly in areas of 
somatomotor and limbic-paralimbic regions has been seen in SIDS cases suggesting a central 
nervous system insult may contribute to SIDS (Kinney et al., 1991). Studies investigating the 
association between smoking and the development of SIDS have highlighted similar 
abnormalities in the central nervous system. Storm et al conducted a pathological 
examination of the brainstem of SIDS victims and showed gliosis of the inferior olivary 
nucleus in infants of mothers who smoked; the degree of gliosis correlated significantly with 
the number of cigarettes smoked during pregnancy (Storm et al., 1999).  
 
High levels of cotinine in the fetus are associated with effects on both cell replication and 
programmed cell death (apoptosis) (Slotkin et al., 1997a). The neuronal injury in the brain 
stem found in many SIDS victims has consequently been ascribed to tobacco smoke exposure 
(Krous et al., 1981), although it is not clear whether the neuronal damage is a primary toxic 
effect of substances in tobacco smoke or secondary to hypoxic or ischemic episodes that may 
be associated with smoking exposure (Rognum and Saugstad, 1991). 
 
Nicotine stimulates cholinergic neurons and the release of dopamine and noradrenaline from 
synaptic nerve terminals in the brain and elsewhere (Benowitz, 1990) Dopaminergic neurons 
are predominantly involved with regulation of neuroendocrine functions, locomotion and 
reward-seeking behavior (Goldman-Rakic, 1998) (Schultz, 1997) (Wooten, 1997). Dopamine 
mediated functions adversely changed by fetal nicotine exposure include hyperactivity 
(Richardson and Tizabi, 1994) and disturbances in cortisone and pituitary hormones release 
(Fuxe et al., 1989). Dopamine concentration was decreased in the ventral tegmental area and 
the striatum in offspring of nicotine-treated dams, timed-pregnant Sprague-Dawley rats 
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(Richardson and Tizabi, 1994). Noradrenergic neurons regulate a variety of autonomic 
functions including responses to stress (Esler et al., 1995, Page and Valentino, 1994, 
McCormick et al., 1991). Noradrenaline mediated functions adversely affected by nicotine 
include a decreased ability for sympathetic activation in response to exogenous stress (Page 
and Valentino, 1994). 
 
1.2.4  Cardiopulmonary effects of exposure to maternal smoking   
 
Two possible explanations for the increased risk of SIDS in mothers who smoked during 
pregnancy are a reduced ability to recover from prolonged apnea or insensitivity to hypoxia 
or hypercarbia. There is evidence from both humans and animals studies that exposure to 
tobacco smoke or nicotine during pregnancy affects fetal development of the brainstem where 
the main cardiorespiratory centers are localized (Slotkin et al., 2005) (Lavezzi et al., 2005) 
(Slotkin et al., 2011). Prenatal cigarette smoke exposure (CSE) results in apoptotic cell death 
in the brainstem regions that control respiratory activity (Nie et al., 2013).  
 
Although some studies in human infants observed no significant difference in respiratory 
drive between the infants of smokers and non-smokers (Schuen et al., 1997) (Poole et al., 
2000) (Campbell et al., 2001). Others showed that 2- 24 months old infants born to smoking 
mothers have a reduced drive to breath during normoxia and a diminished ventilatory 
response to hypoxia (Ueda et al., 1999). Moreover, infants of mothers who smoked 
antenatally prior to maternity unit discharge (ie, before passive postnatal smoke exposure) 
had a dampened ventilatory response to hypercarbia when compared to controls. This meant 
that the time constant of the infant’s response in increasing their minute ventilation to 
compensate for the added dead space was longer (Bhat et al., 2005). Hypercarbia is the most 
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important stimulus to ventilation with added dead space; therefore, those results are 
compatible with dampened chemoreceptor function in infants exposed to cigarette smoking in 
utero (Bhat et al., 2005). In contrast to those observations, another study found that 
ventilatory responses to hypoxia and hypercapnia were not different between 2-3 months 
aged infants of smoking mothers and controls. It was noted however, that  infants of mothers 
who smoked during pregnancy had a deficient arousal response to hypoxia (Lewis and 
Bosque, 1995).  
 
There is also conflicting evidence from animal studies.  For example, studies in neonatal rats 
in vivo indicated that no significant effect of prenatal nicotine exposure was found on 
ventilatory responses to moderate hypoxia or hypercapnia (Bamford et al., 1996)  (Poole et 
al., 2000). However, another study showed that the ventilatory response to hypoxia was 
significantly attenuated during quiet sleep in nicotine-exposed neonatal lambs (Hafstrom et 
al., 2002). It was also found that continuous infusion of nicotine to pregnant rats from day six 
of gestation to days five or six postpartum resulted in an impairment in the ability of the 
newborn pups to auto-resuscitate from primary apnea during repeated exposure to hypoxia 
(Fewell and Smith, 1998). In addition, rat pups exposed to nicotine during fetal life exhibited 
deficient adrenomedullary catecholamine release in response to hypoxia. As a result, the rats 
died at the same hypoxic levels that unexposed rat pups survived without major ill effects 
(Slotkin et al., 1995). The pups also lacked the normal increase in heart rate that should occur 
in response to hypoxia (Slotkin et al., 1997b). Infusion of nicotine in lambs at mean ages of 7, 
17, and 27 days resulted in attenuation of the ventilatory response to hypoxia and 
augmentation of the response to hyperoxia, suggesting that exposure to nicotine altered 
peripheral chemoreceptor oxygen sensitivity and it may have also affected the central 
processing of the chemoreceptor input (Milerad et al., 1995). Data from animal studies 
32 
 
suggest that nicotine interferes with the postnatal resetting of oxygen sensitivity of the 
peripheral arterial chemoreceptors by increasing carotid body tyrosine hydroxylase mRNA 
and dopamine release (Holgert et al., 1995). Similarly, prenatal Cigarette Smoking Exposure 
(CSE) impaired responses to hypoxia in vitro in medullary slice preparations from neonatal 
rats (Nie et al., 2013). Studies in neonatal mice medullary slices indicated that prenatal 
nicotine exposure switches cholinergic mechanisms of central chemosensory responses from 
muscarinic receptors to nicotinic receptors. Modification of the cholinergic contribution to 
central chemoreception may produce respiratory dysfunctions (Coddou et al., 2009). Indeed, 
nicotine is only one of the toxic components of cigarette smoke and many other ingredients 
can cross the placenta barrier to reach the fetus such as carbon monoxide. Carbon monoxide 
from cigarette smoke can cross the placenta barrier and inhibit the release of oxygen into fetal 
tissues (Longo, 1976). Recurrent intrauterine hypoxic insults affect the development of the 
fetal central nervous structure, where the retrotrapezoid nucleus (RTN) the most important 
central chemoreceptor, is localized (Guyenet et al., 2008) 
 
Serotonin (5 hydroxytryptamine, 5-HT) neurons play a key role central chemoreception 
(Richerson, 2004). There is now emerging evidence that prenatal exposure to alcohol and 
cigarette smoke is associated with harmful effects on the development of the human 
medullary 5-HT system (Kinney, 2009). Exposure to maternal smoking, alcohol and cocaine 
also causes upregulation of the 5 HT transporter (5HTT) which is the key regulator of the 
5HT levels at the synapse (Awtry and Werling, 2003),(Bauman et al., 2000), (Kelai et al., 
2003). There is recent evidence from animal studies in mice that prenatal-perinatal exposure 
to nicotine alter the activity, electrical properties and central chemosensitivity of the raphe 




Another tentative mechanism by which smoking increases the risk of SIDS is an increased 
risk of respiratory infections in infancy. Infants who live in smoking environment have more 
frequent upper airway infections than infants in non-smoking homes (Taylor and Wadsworth, 
1987)  Nicotine may enhance adverse immunological reactions to trivial bacterial infections 
and induces fatal outcomes  in chick embryos (Sayers et al., 1995). The proposed mechanism 
may be an immunological potentiation of the antigenic properties of staphylococcal toxins by 
nicotine (Blackwell et al., 1994). 
 
Prenatal Cigarette Smoking Exposure (CSE), has been shown to affect lung volume (Tager et 
al., 1995) (Hanrahan et al., 1992) and passive lung mechanics ( compliance and resistance) 
(Hanrahan et al., 1996). Another study in newborns of smoking mothers at median age of 2.7 
days showed that maternal smoking affected tidal flow-volume ratios and compliance of the 
respiratory system in girls, independently of the reduced body size (Lodrup Carlsen et al., 
1997). The mechanism by which maternal smoking induces the reduction in lung size has not 
been specifically elucidated. One important factor is that smoking decreases fetal breathing 
and the decrease in rhythmic mechanical distension of airways by fetal breathing movements 
hampers normal lung growth (Moessinger et al., 1990). 
 
Since the majority of these changes are already present at birth they are not likely to be 
produced by the irritant effect of tobacco smoke but are rather a consequence of a suboptimal 
fetal organ growth (Mitchell and Milerad, 2006), (Milner et al., 2007). 
It is also important to determine whether antenatal smoking affects chemoreceptor responses 
to hypercarbia and hypoxia both in the perinatal period and at the peak age for SIDS, which is 
an important aim of this thesis    
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1.2.5 Cotinine  
 
Cotinine, the major proximate metabolite of nicotine, is widely used as a biomarker of 
tobacco exposure (Benowitz, 1996, Benowitz et al., 2009b). It is produced by the metabolism 
of nicotine in the liver by cytochrome P 450 which converts almost 75% of the nicotine to 
cotinine (Hukkanen et al., 2005).  Cotinine passes readily through the placenta and can be 
measured both in maternal and umbilical cord serum. Umbilical cord cotinine is considered 
the gold standard of measuring fetal tobacco exposure.(Pichini et al., 2000). Cotinine’s half-
life is longer (12-36 h) than nicotine’s (2 h) (Kyerematen and Vesell, 1991, Pilotti, 1980). 
Urine cotinine concentrations average fourfold to six-fold higher than those in blood or 
saliva, making urine a more sensitive matrix to detect low-concentration exposure (Benowitz 
et al., 2009a).    Indeed, cotinine provides a specific and objective assessment of the 
individual’s actual smoking exposure to allow assessment of exposure-response relationships. 
Several studies used levels of cotinine and other biochemical metabolites of nicotine to both 
validate self-reported smoking practices during pregnancy (Eliopoulos et al., 1994) (Haley et 
al., 1983) and predict pregnancy outcomes such as birth-weight (Haddow et al., 1987, 
Haddow et al., 1988, English et al., 1994). In this thesis, therefore, maternal smoking will be 















1.3 Maternal substance abuse and SIDS:  
 
1.3.1 Prevalence of substance misuse during pregnancy 
 
A survey carried out by the Office for National Statistics on behalf of the Department of 
Health showed that approximately one in a thousand women in Great Britain is dependent on 
opioids; the majority of these women were of child bearing age (Psychiatric Morbidity 
Amongst Adults Living in Private Households. London: Office for National Statistics, The 
Stationary Office; 2001.) Anonymous urine testing in pregnant mothers in the East of London 
found that 10.6% of urine samples were positive for illicit drugs (Farkas et al., 1995) A 
similar study in South London highlighted that 16% of women at pregnancy booking had 
evidence of substance misuse on the basis of urine toxicology screening,(Sherwood et al., 
1999) suggesting that one in six women in South London were misusing drugs in early 
pregnancy. A survey of English and Welsh maternity units in 1993 estimated the number of 
babies born to substance-abusing mothers was 0.81 per 1000 deliveries (Patni et al., 2008) 
 
A higher prevalence of maternal substance misuse has been reported from some, but not 
all, population-based studies in the United States. Ostrea and colleagues reported a 31% 
prevalence of cocaine use during pregnancy based on toxicological screening of meconium at 
birth; 44% of 3010 babies tested positive for opiates, cocaine, or cannabis (Ostrea et al., 
1992). A study in Boston, in which cocaine use was assessed by interviews during pregnancy 
and urine samples obtained prenatally and immediately postpartum demonstrated that 28% of 
urine samples tested positive for marijuana and 17% for cocaine or its metabolites (Frank et 
al., 1988). Of the cocaine users, 24% denied use at the time of the interview and were 
identified solely by urine assay(Frank et al., 1988). A study from Florida, however, reported 
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only a 14.5% prevalence of maternal substance misuse during pregnancy (Chasnoff et al., 
1990). 
Maternal substance misuse behaviour is changing, with the emergence of synthetic drugs 
such as mephedrone, also referred to as ‘Meow Meow’ or ‘M-Cat’. A Home Office report on 
the use of khat, a shrub which is chewed for its stimulatory effects predominately by people 
from east Africa and the Arabian peninsula, found that in four UK cities (London, Bristol, 
Birmingham, and Sheffield) 34% of the 602 Somalis interviewed reported using the plant 
leaves (http://webarchive.nationalarchives.http://rds.homeoffice.gov). 
Opioid use among pregnant women is increasing (Epstein et al., 2013, Desai et al., 2014, 
Bateman et al., 2014, Salihu et al., 2015). National trend data from United States showed that 
from 1998 to 2009, opioid use was documented in 138,224 of 55,781,966 pregnancy-related 
inpatient hospitalizations (25 cases per 10,000 discharges). A statistically significant 
downward trend occurred from 1998 to 2001, whereas from 2002 to 2009 there was a 
statistically significant upward trend. The increasing trend in opioid use from 2002 to 2009 is 
notably higher for whites compared with blacks and Hispanics (Salihu et al., 2015). The 2009 
National Survey on Drug Use and Health, the primary source of statistics on illicit drug use in 
the United States, estimates that 4.5% of pregnant women (15–44 years) used illicit drugs in 
the month before the survey (National Survey on Drug Use and Health: 2010. 
www.oas.samhsa.gov).  One recent study found that prevalence of chronic medical use of 
prescription narcotics during pregnancy increased significantly from approximately 2.5 per 
1,000 deliveries in 2000 to over 10.0 per 1,000 deliveries in 2008. (Kellogg et al., 2011) This 
is consistent with the documented increase in therapeutic and nonmedical use of prescription 
pain relievers in the United States.(Okie, 2010, Manchikanti et al., 2010). Data from 
Washington state showed that drug exposure and neonatal abstinence syndrome rates 
increased significantly between 2000 and 2008, neonatal abstinence syndrome rates were 
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higher than national figures (3.3 compared with 2.8 per 1,000 births in 2008; P<0.05). The 
proportion of neonatal abstinence syndrome-diagnosed neonates exposed prenatally to 
opioids increased from 26.4% in 2000 to 41.7% in 2008 (P<0.05). Compared with unexposed 
neonates, drug-exposed and neonatal abstinence syndrome-diagnosed neonates had a lower 
mean birth weight, longer birth hospitalization, were more likely to be born preterm, 
experience feeding problems, and have respiratory conditions (Creanga et al., 2012). A recent 
large national cohort of nearly 300 centres in the United States, found increases from 2004 
through to 2013 in patient admissions, length of stay and resource utilization for infants 
admitted to NICUs with the neonatal abstinence syndrome (Tolia et al., 2015) 
 
1.3.2  SIDS and substance misuse during pregnancy 
 
1.3.2.1  Cocaine 
Some reports suggested that the SIDS rate was higher in infants who were exposed to cocaine 
prenatally. In one report, the SIDS rate was 15% amongst 66 infants who were prenatally 
exposed to cocaine compared to 4% amongst infants exposed to opiates (Chasnoff et al., 
1989). A study in California found that of the 1137 infants born of substance-abusing women 
(16% of total births), 85% were exposed to cocaine. Ten died of SIDS at an incidence rate of 
8.8/1000 (Durand et al., 1990) which was significantly higher than the incidence of SIDS 
among the 5946 infants who had no drug exposure (1.3/1000) (Durand et al., 1990). In 
contrast, in a study of 175 cocaine-abusing mothers and 821 controls, only one infant of the 
cocaine abusing mothers died, yielding a SIDS incidence of 5.6/1000, which was similar to 
the incidence of 4.9/1000 amongst non-exposed offspring (Bauchner et al., 1988). In 
addition, in a study of 1780 SIDS cases from a population of more than a million infants in 
New York City between 1979 and 1989, SIDS rates were 5.89 per 1000 births for drug-
38 
 
exposed infants compared to 1.39 per 1000 control infants (Kandall et al., 1993). When 
adjustment was made for confounders, the association between increased SIDS rates and drug 
use remained significant for opioid use (methadone, heroin, or methadone and heroin), but 
not for cocaine alone or cocaine with opioids. A subsequent meta-analysis of 10 studies 
reported that the odd ratio (OR) of SIDS in infants born to mothers who used cocaine during 
pregnancy was 4.10 (95% confidence interval [CI]: 3.17–5.30) (Fares et al., 1997), but there 
was no increased risk of SIDS related to prenatal cocaine exposure compared to exposure to 
other drugs. In addition, it was emphasized that as cocaine use is correlated with many 
potential risk factors, large sample sizes and multivariate statistical techniques are needed to 
determine whether cocaine use is an independent risk factor for adverse neonatal outcomes. 
In one series, (Frank et al., 1988) cocaine users were significantly less likely than nonusers to 
be married, but were more likely to have sexually transmitted diseases, prior low birth weight 
infants, spontaneous and elective abortions, and greater use of alcohol, cigarettes, and other 




Infants born to opiate-abusing mothers have been shown to be five to ten times more likely to 
be at risk of SIDS than the general population (Ward et al., 1990). A study from New York 
examining a cohort of 383 infants born of substance-abusing mothers recorded a SIDS 
incidence of 20.9 per 1000 infants (Rajegowda et al., 1978). The study found that no SIDS 
deaths were attributable to heroin use alone, but 4 of 106 infants who were born to mothers 
who abused heroin and methadone died of SIDS (Rajegowda et al., 1978). The other four 
cases of SIDS were born to 182 mothers who were on a methadone treatment program 
(Rajegowda et al., 1978). Chavez et al reported 17 cases of SIDS in infants born to 688 drug-
using mothers (24.7 per 1000 births) (Chavez et al., 1979). Although 14 of the 17 mothers of 
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SIDS victims were enrolled in methadone treatment programs, the majority of the mothers 
continued to use other drugs such as heroin, cocaine, diazepam, and amphetamines. A 
retrospective study of all live births to women in New South Wales during the period 
encompassing 1995–2002 found that the infant mortality rate was high amongst infants 
whose mothers were on methadone during pregnancy (24.3 per 1000 live born infants) (Burns 
et al., 2010) 
 
1.3.2.3  Marijuana (cannabis) 
 
Marijuana is the most frequently used illicit substance in the Western world; 32% of those 
living in urban areas in the United States (US) were reported to use marijuana (Streissguth et 
al., 1991). Maternal use of marijuana, however, does not appear to increase the risk of SIDS. 
In a case-control study in southern California examining 239 infants who died of SIDS and 
239 matched healthy infants, no association between maternal recreational drug use and SIDS 
was found (Klonoff-Cohen and Lam-Kruglick, 2001). In the same study, It was noted that 
paternal marijuana use during conception (OR = 2.2, 95% CI: 1.2–4.2), pregnancy (OR = 2.0, 
95% CI: 1.0–4.1), and postnatally (OR = 2.8, 95% CI: 1.1–7.3) was significantly associated 
with an increased risk of SIDS after adjusting for paternal smoking and alcohol abuse. The 
results of that study, however, were from telephone interviews of parents 6 to 12 months after 
the infant’s death, and it would be important to undertake further investigation to confirm or 
refute this association. 
 In a study carried out in the UK (the Avon Longitudinal Study of Pregnancy and Childhood), 
the use of cannabis during pregnancy was not associated with an increased risk of perinatal 
mortality or morbidity; however, frequent and regular use of cannabis during pregnancy was 
associated with a small but statistically significant reduction in birthweight (Fergusson et al., 
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2002). The adjusted mean birth weights of babies who are born to women who used cannabis 
at least once per week before and throughout pregnancy were 90 g lighter than offspring of 
other women (Fergusson et al., 2002). In a study in South London, (Sherwood et al., 1999) 
cannabis use in early pregnancy was also associated with a reduction in birth weight, a lower 
gestational age at delivery, and an increased risk of prematurity.  
 
1.3.2.4  Stimulants 
 
Twenty million people consume khat on a daily basis in Africa, and a further 10 million 
people worldwide may use it regularly (Matloob et al., 2010). The effect of chewing khat 
leaves produces a stimulatory and euphoric sensation similar to that produced by a mild 
amphetamine. Although, there are no studies reported which have explored the association 
between maternal use of Khat during pregnancy and subsequent SIDS, use of khat is 
associated with low birth weight, (Abdul Ghani et al., 1987) a risk factor for SIDS. 
Mephedrone (4-methylmethcathinone) is a novel synthetic stimulant drug that has recently 
become popular in the UK and Europe. A recent survey found that mephedrone was the sixth 
most frequently used drug after tobacco, alcohol, cannabis, cocaine, and 3,4-
methylenedioxymethamphetamine. (Winstock et al., 2011) The survey highlighted that the 
majority of ephedrine abusers were of young age; the drug has comparable abuse potential to 







1.3.3  Respiratory control abnormalities in infants of substance-abusing mothers  
 
 
A variety of respiratory abnormalities have been reported in infants of substance-abusing 
mothers. A significantly smaller fall in end-tidal carbon dioxide levels in response to a 
hypoxic challenge, and a significant impairment in arousal responses to hypoxia in infants of 
substance-abusing mothers have been reported (Ward et al., 1992). Reduced carbon dioxide 
sensitivity in newborns of substance-abusing mothers has also been highlighted (Wingkun et 
al., 1995). It has been postulated that ventilatory control abnormalities could lead to abnormal 
sleeping ventilatory patterns, (Ward et al., 1986) which might contribute to the increased risk 
of SIDS among infants of substance-abusing mothers. Indeed, in one study, (Ward et al., 
1986)32% of pneumograms from infants of substance-abusing mothers were abnormal 
compared to 9.3% of pneumograms among controls. The infants of substance-abusing 
mothers had longer sleep times, a higher total duration of apneas greater than or equal to 6 
seconds, and more periodic breathing (Ward et al., 1986). 
Abnormalities specific to certain types of prenatal drug exposure (including cocaine and 
methadone) have been reported. Infants prenatally exposed to cocaine had a higher incidence 
of cardiorespiratory pattern abnormalities; that is, more frequent apneas and greater intervals 
of periodic breathing than infants exposed antenatally to methadone (Chasnoff et al., 1989). 
Apnea density and episodes of periodic breathing exceeded the 95th percentile for normal 
infants among 38% of cocaine-exposed infants, but only 6% (one in 18) of methadone-
exposed infants (Chasnoff et al., 1989). In addition, five infants exposed to cocaine (but no 
infants exposed to methadone) had apnea (Chasnoff et al., 1989). A higher frequency of 
respiratory pauses and a greater decrease in minute ventilation in response to facial air stream 
stimulation has been reported in infants exposed prenatally to cocaine compared to controls 
(Chen et al., 1991).  
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Infants exposed to methadone in-utero were demonstrated to have decreased sensitivity to a 
carbon dioxide challenge when compared to controls, as measured by the slope of the 
ventilatory response curve during the first weeks after birth (Olsen and Lees, 1980).The 
depressed ventilatory response to carbon dioxide lasted on average for 15 days after birth 
(Olsen and Lees, 1980).  
There are however no longitudinal data on the response of SM infants to hypercarbia nor data 
on their response to hypoxia. Hence, a further aim of this thesis is to study this. 
The majority of women who engage in substance misuse also smoke, and thus some of the 
respiratory control abnormalities seen in infants of substance-misusing women may, at least 
in part, relate to their smoking. Therefore, it would be important to compare the responses of 
infants of mothers who substance misused to those who only smoked 
 
1.4 Peripheral chemoreceptors and ventilatory response to hypoxia in newborns and 
infants   
 
Peripheral chemoreceptors monitor changes in arterial blood O2, and within seconds after the 
onset of hypoxia they trigger cardiorespiratory changes (i.e., increase in breathing and blood 
pressure), which are important for maintaining O2 homeostasis. Conventionally, peripheral 
chemoreceptors are thought to comprise carotid and aortic bodies. However, tissues similar to 
carotid and aortic bodies have also been described in thorax and abdomen, which are often 
called “paraganglion” and may serve as additional chemoreceptors (Easton and Howe, 1983) 
(Deane et al., 1975) 
Newborns and infants have a biphasic response to hypoxia. The biphasic response to hypoxia 
consists of an immediate (30 secons-1 min) increase followed by later decline (5 min) in 
minute volume to often below normoxic levels (Neubauer et al., 1990). It was first described 
in the newborn by Cross et al in 1952 (Cross and Oppe, 1952). In their study, Cross and Oppe 
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showed that infants breathing 15% oxygen had an immediate but a rather transient increase 
followed by decline in minute ventilation. They suggested that despite the evidence of active 
chemoreceptor response to hypoxia, it was not effective in maintaining hyperventilation if the 
hypoxia was prolonged beyond two minutes (Cross and Oppe, 1952). The authors suggested 
that the late depression in ventilation was secondary to anoxic effects on the medullary 
centres.  Similar findings of biphasic ventilator response to hypoxia were also described in 
other studies in the newborn by the same group (Cross et al., 1954, Cross et al., 1958) and by 
other in term (Brady and Ceruti, 1966) and preterm infants (Rigatto et al., 1975, Nock et al., 
2004, Martin et al., 1998). The biphasic response to hypoxia was also described in a series of 
animal studies (Rigatto and Brady, 1972a, Gershan et al., 1994, Haddad et al., 1982, Mortola 
et al., 1989, Rigatto et al., 1988).  
Adult’s hypoxic ventilatory response differs from the biphasic response described above in 
newborns and infants both in terms of the magnitude of change in minute volume and the 
time course of the response (Easton et al., 1986, Weil and Zwillich, 1976). The ventilatory 
response to hypoxia in adults consists of an initial increase in ventilation that peaks within 3–
5 min and is sustained for approximately 15–30 min before a subsequent decline to pre-
hypoxic baseline values (Douglas et al., 1982). 
The initial increase in ventilation in response to hypoxia newborns and infants is mediated 
through the peripheral arterial chemoreceptors located in the carotid and aortic bodies.  
Hypoxia is initially associated with an increase in both respiratory frequency and tidal 
volume (Rigatto et al., 1975, Rigatto, 1977).  
Different mechanisms have been suggested to explain the cause of the ventilatory depression 
that follows the initial increase in ventilation. Cross et a1 (Cross et al., 1954),  first suggested 
that the late decline in ventilation was likely due to the central depressant effects of hypoxia. 
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He later suggested that a decline in metabolism was also a possible cause (Cross et al., 1958). 
Subsequent studies have attributed the late decline in ventilation during hypoxia to a variety 
of mechanisms including, a decrease in metabolism (Mortola and Matsuoka, 1993, Mortola et 
al., 1989), change in breathing pattern(Rigatto and Brady, 1972b) ,  decrease in compliance 
(LaFramboise et al., 1983) or a decrease in temperature (Adamsons, 1959, Cross et al., 1959). 
LaFramboise et al (LaFramboise et al., 1983) suggested the influence of mechanical factors 
since their study in a monkey preparation showed undiminished central output in the presence 
of decreased ventilation during late hypoxia. Tidal volume decreased significantly and was 
the primary factor responsible for the decrease in ventilation, with frequency remaining 
elevated. Rigatto et (Rigatto et al., 1988)   found similar results in the unanesthetized kitten, 
with a predominant decrease in VT. Similarly, a decrease in compliance due to 
bronchoconstriction was suggested, but the observations of a bronchodilatory effect in 
response to hypoxia in 70 of 76 airways studied with high-resolution tomography seem to 
make this possibility unlikely (Wetzel et al., 1992) . A decrease in temperature may 
accentuate the biphasic response, with a more pronounced late decrease in ventilation, but 
some studies have demonstrated that the response clearly occurs during thermo neutrality 
(Brady and Ceruti, 1966). Many studies have demonstrated a decrease in metabolism during 
hypoxia, in both animals (Gershan et al., 1994, Haddad et al., 1982, Mortola et al., 1989) and 
humans (Cross et al., 1958) . A decrease in metabolism would induce a corresponding 
decrease in ventilation mediated through a decrease in CO2, production (Mortola and 
Matsuoka, 1993) .  Therefore, the more likely explanation for the late decrease in ventilation 
during hypoxia appears to be a decrease in metabolism, a central respiratory depression, or 
both.  
The central sites responsible for the hypoxic ventilatory decline have been suggested to exist 
in the upper medulla by Cross et al (Cross et al., 1954) or above the midcolliculi by Dawes 
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and co-workers (Dawes et al., 1983) . In the experiments of Dawes et al, (Dawes et al., 1983) 
hypoxia stimulated breathing in the midcollicularly transected fetal sheep, suggesting the 
possibility of an inhibitory action of hypoxia on a center located rostral to the section level. 
Johnston and co-workers (Gluckman and Johnston, 1987, Johnston and Gluckman, 1993), 
have localized a specific area in the rostral lateral pons, in the region of the lateral 
parabrachial and Kolliker-fuse nuclei, which appears to be involved in the central inhibition 
of breathing during hypoxia in the fetal lamb. After electrolytic lesions of this area, 
hypoxemia stimulated rather than abolished breathing in the fetus. This appears likely to be 
the site of action for neurotransmitters that are released by hypoxia and inhibit breathing. 
There is clear evolution of the hypoxic ventilatory response from fetal life to neonatal 
period/infancy and later on in adults: hypoxia causes ventilatory depression in the 
fetus(Alvarez et al., 1992), stimulates and depresses ventilation it in the newborn (Cross and 
Oppe, 1952, Cross et al., 1954, Rigatto et al., 1975, Rigatto, 1977, Rigatto and Brady, 1972a), 
also stimulates and depresses ventilation it in the adult, but less so than  the newborn (Easton 
et al., 1986, Weil and Zwillich, 1976). The evolution is therefore one of gradual diminishing 
degree of ventilatory depression with increasing age.  
There is conflicting evidence regarding the time of maturation of the ventilatory response to 
hypoxia in infants and the actual age at which infant’s hypoxic ventilatory response becomes 
similar to the adult response. Some studies have shown that the immature biphasic HVR 
existed up to 2 months of age (Cohen et al., 1997, Martin et al., 1998). In another study, the 
immature biphasic response to hypoxia persisted until 5-6 months of age (Richardson et al., 
2007) 
It is therefore important in assessing the response to hypoxia in SM and S infants to recruit a 
control group and this will be done in this thesis. 
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1.5 Central chemoreceptors and the responses to hypercapnia in newborns and 
infants  
 
The sensitivity of the central chemoreflex may be estimated using either rebreathing or 
steady- state methods to increase carbon dioxide while maintaining hyperoxia to reduce the 
peripheral- chemoreflex ventilatory response (Cunningham, 1987). While some investigators 
report no difference in central-chemoreflex sensitivities between the two methods, (Read, 
1967, Clark, 1968, Oren et al., 1991, Soto Campos et al., 1996), others report higher 
sensitivities for rebreathing compared to steady-state methods (Berkenbosch et al., 1989, 
Bourke and Warley, 1989)  
The ventilatory response to hypercapnia is dependent on the relative size and maturity of the 
species at birth, and generally increases with postnatal age (Bonora et al., 1994), in part as a 
result of increasing sensitivity of both central and peripheral chemoreceptors (Davis et al., 
2006) (Hanson et al., 1989). Newborn animals and premature and mature infants increase 
ventilation when breathing low concentrations of CO2 (Guthrie et al., 1980) (Haddad et al., 
1980, Rigatto et al., 1980) (Rigatto et al., 1981). Tidal volume is increased with little or no 
effect on breath timing, so that the calculated "central inspiratory drive" (VT/T1) is increased. 
The hypercarbic ventilatory response of most newborn species is reduced compared with that 
of adults(Carroll et al., 1993, Carroll and Fitzgerald, 1993, Davis et al., 2006), unlike 
hypoxia, it is sustained over time by a persistent increase in tidal volume (VT), despite a 
gradual decline in the initial respiratory frequency (f) (Bonora et al., 1994) (Cummings and 
Frappell, 2009) .  
Inhalation of very low concentrations of CO2 (0.3-1.2%) in infants was shown to make 
periodic and irregular breathing more regular; breath frequency increased and tidal volume 
fell (Rigatto et al., 1980).  When breathing was regular, CO2 inhalation tended to increase 
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tidal volume with little change of breath timing (Kalapesi et al., 1981). This shows that there 
is significant interaction between the central effects of CO2 and the neural mechanisms that 
determine the ongoing respiratory pattern.  
There is conflicting evidence regarding the influence of sleep stage on the ventilatory 
response to hypercapnia. A difference in resting ventilation and in the response to CO2 when 
REM (Rapid Eye Movement) and NREM (Non-Rapid Eye Movement) sleep episodes were 
compared was not apparent in newborn monkeys before 3 weeks of age (Guthrie et al., 1980), 
nor in premature infants (Kalapesi et al., 1981, Rigatto et al., 1980) or term infants until about 
3 months(Haddad et al., 1980) . A small increase of ventilation during sleep was noted in l l-
week-old infants in one study (Fagenholz et al., 1976). The definitive sleep pattern is laid 
down gradually over several months, and there must be some difficulty in distinguishing each 
sleep state clearly in the very young infant. Oxygen consumption and the thermoregulatory 
response to cooling were also similar in both sleep states in premature infants (Darnall and 
Ariagno, 1982); this differs from the adult, where O2 consumption is higher and the fall of 
body temperature greater during cooling in REM sleep. Thus, sleep-related mechanisms that 
modulate breathing, metabolism, thermoregulation, and the response to CO2 do not operate 
fully in the newborn primate (Walker, 1984). 
Infants who had had an apnea requiring resuscitation had a greater ventilatory response to 
inhaling 2% CO2 than age-matched controls (Haddad et al., 1981) . These infants also had 
higher resting heart rates and shortened QT intervals; it was suggested that increased 
sympathoadrenal activity caused the raised CO2 response, since infusion of catecholamines in 
the adult is known to increase the slope of the CO2 response curve. Others have not observed 
altered CO2 sensitivity when infants showing prolonged (>20 sees) spontaneous apnea were 
compared to those with regular breathing (Fagenholz et al., 1976). Infants with persistent 
hypoventilation during sleep had a very low sensitivity to CO2, an effect attributed to 
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impairment of central CO2 sensitivity, because peripheral chemoreceptor responses appeared 
to be normal (Lagercrantz et al., 1980, Shannon et al., 1976) (Wells et al., 1980) 
 Data on ventilatory responses to hypercarbia are sparse at the peak age of SIDS thus it would 
be important to assess the infants response to hypercarbia in the perinatal period and at the 





















1.6 Summary  
 
Infants of substance abusing mothers have a number of risk factors for Sudden Infant Death 
Syndrome (SIDS), but after controlling for other high risk variables, their rate of SIDS is 
higher than that of the general population. There is some evidence to suggest that infants of 
substance abusing mothers have a disruption in the maturation of respiratory control. The 
profile of drug abuse, however, has changed since those studies and there are no data from 
infants of substance abusing mothers at the high-risk age for SIDS.  
Women who substance-misuse during pregnancy, almost always smoke and infants of 
mothers who smoke during pregnancy are also at high risk for SIDS.  Thus, essential to 
understanding why infants of substance abusing mothers are at increased risk of SIDS, is to 
compare their results with infants whose mothers neither substance abused nor smoked 
(controls), but also to those of infants whose mothers smoked during pregnancy. There are no 
data available comparing chemoreceptor responses in new-borns and infants of smoking, 
substance-abusing and non-smoking/non-substance-abusing (controls) mothers. There is also 
limited longitudinal data on chemoreceptor responses in infants of smoking and substance-
abusing mothers. By assessing the infants twice, I will determine if there are changes with 










1.7 Hypotheses  
 
 
 Infants of substance abusing mothers and infants of mothers who smoke will 
have poorer ventilatory responsiveness to hypercarbia and hypoxia and 
reduced chemoreceptor sensitivity compared to controls 
 Impairment of ventilatory responsiveness and reduced chemoreceptor 
sensitivity will be greater in the infants of mothers who both substance abuse 
and smoke compared to those whose mothers only smoke  
 

















1.8 Aims  
 
To assess the correlation between maternal reported smoking and urinary cotinine levels  
 
To describe the profile of maternal substance-misuse  
 
To study the effect of maternal smoking and substance misuse during pregnancy on the 
ventilatory response to hypercapnia in the perinatal period 
  
To study the effects of maternal smoking and substance misuse during pregnancy on infant’s 
ventilatory response to hypercapnia at the peak age of SIDS 
 
To study the effects of maternal smoking and substance misuse during pregnancy on infant’s 
ventilatory response to hypoxia in the perinatal period 
 
To study the effects of maternal smoking and substance misuse during pregnancy on infant’s 
ventilatory response to hypoxia at the peak age of SIDS 
 
To study the maturation of the ventilatory response to hypercapnia with increasing postnatal 
age  
 





























2.1  Subjects   
2.1.1  Inclusion criteria 
Infants were eligible for entry into the study if they were born at 36 weeks of gestational age 
or greater at King’s College Hospital NHS Foundation Trust. Informed written parental 
consent was obtained and the study was approved by the Guy’s and St Thomas’s Hospitals 
NHS Foundation Trust Research Ethics Committee.   
Three groups of mothers/infants were recruited in the antenatal and/or immediate neonatal 
period: 
1. Mothers with a history of substance misuse during pregnancy were approached 
antenatally in a dedicated substance misuse clinic (SM infants) 
2. Infants whose mothers gave a history of smoking during pregnancy. Smoking was 
defined as any history of daily smoking regardless of the number of cigarettes 
smoked/day (S infants) 
3. Infants whose mothers neither smoked nor misused substances during pregnancy 
(controls) 
  
2.1.2 Exclusion criteria 
 
Infants were not included in the study if they had congenital anomalies, significant 








Infants were first studied in the immediate newborn period before discharge from the 
maternity unit. The infants were also studied at 6-12 weeks of age in a purpose built infant 
assessment unit.   
 
2.3 Assessment of exposure to smoking and the type and amount of substance misuse 
2.3.1  Smoking  
 
Mothers with history of smoking were asked about the average number of cigarettes smoked 
per day. Maternal self-reported number of cigarettes smoked was related to the results of 
cotinine analysis. 
 
2.3.1.1 Laboratory measurement of cotinine  
The detection of smoking by measurement of nicotine metabolites such as cotinine is 
favoured over other methods, such as carboxyhaemoglobin or thiocyanate determinations. 
This is partly because cotinine and other nicotine metabolites are tobacco specific, whereas 
carboxyhaemoglobin and thiocyanate may be present as a result of exposure to other 
environmental factors. Moreover, cotinine has a longer half-life of (2-3 days) than nicotine or 
carboxyhaemoglobin. The measurement of cotinine is an aid to confirm the smoking status as 
well as quantifying the magnitude of smoking. 
 Maternal and infant urine cotinine levels were measured in the immediate perinatal period 
 Urine sample were collected into a universal container without preservative. Samples were 
assayed immediately or aliquoted and stored at -20° C. Samples are centrifuged before 
analysis. Cotinine reagent was supplied by Siemens Healthcare Diagnostics Ltd. This analyte 
was measured on the Siemens Immulite 2000 analyser. The assay is a solid phase competitive 
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chemiluminescence immunoassay for the measurement of cotinine in human serum or urine. 
It utilises a rabbit polyclonal antibody, which is bound to a bead and the cotinine is 
conjugated to alkaline phosphatase in the form of a reagent. These reagents were placed on a 
Siemens Immulite 2000. The sample and reagent are incubated together with the coated bead 
for 30 minutes. During this time, cotinine in the sample and cotinine conjugated to alkaline 
phosphatase in the reagent compete for binding sites on the beads. Unbound patient sample 
and excess reagent were then removed by centrifugal washes. Finally, chemiluminescent 
substrate was added to the reaction tube containing the bead and the signal was generated 
which was in proportion to the bound enzyme and inversely proportional to the amount of 
cotinine present in the sample. The cut-off limit for detection of cotinine was 10ng/ml.  
 
2.3.2 Substance misuse 
 
The substance-misuse profile of mothers in the substance misuse group was reviewed. Details 
of the maternal methadone dose during pregnancy were obtained from the medical records of 
mothers on “prescribed” methadone. Results of the urine analyses performed during 
pregnancy were reviewed. 
 
2.3.2.1 Urine drug screen  
In the immediate postpartum period, urine samples were taken from the mothers and 
newborns for drug screen. Urine samples were collected into universal containers without 
preservative. No specific patient preparation was required before collecting the samples and 
no specific timing of sample collection was required. Attempts were made to collect maternal 
and infants sample close to each other, but this was not always feasible. 
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 Screening of the urines was carried out for cannabinoids, opiates, amphetamines, methadone, 
cocaine and benzodiazepines. The urine drug assay works on the (CEDIA) Principal Cloned 
Enzyme Donor Immunoassay. CEDIA technology is based on Beta -galactosidase that has 
been synthesised in two inactive fragments that spontaneously re-associate to form the active 
enzyme. The cut-off concentrations used to determine positivity were as recommended by the 
manufacturer (cocaine 300ng/ml, methadone 100ng/ml, cannabis 25ng/ml, benzodiazepines 
300ng/ml and amphetamines 500ng/ml)  
2.4 Physiological measurements  
 
Infants were studied in the supine position with their head in the midline. All physiological 
measurements were carried out when infants were in quiet sleep.  Sleep state was determined 
by observation of the behavioural state (Prechtl et al., 1979). The infant was determined to be 
in quiet sleep when the eyes were closed, there was no body or eye movement, no 
vocalization and the respiratory rate was regular.    
2.4.1 Hypercarbic challenge 
 
The hypercapnic challenge was delivered via a facemask and pneumotachograph through a 
custom-made open circuit system with individually adjustable flows of CO2 and air (Figure 
2.1). A bias flow of air was passed through the open circuit, eliminating any dead space.  
Respiratory flow was measured using an appropriately sized pneumotachograph (Mercury 
F10L, G M Instruments, Kilwinning, Scotland) with a dead space 0.8ml and a resistance of 
0.86 mmH2O/L/min. A facemask was placed over the infant’s mouth and nose. The 
pneumotachograph was attached to the distal end of the facemask and its distal was 
connected to a two-way non-rebreathing valve.  The pneumotachograph was attached to a 
differential pressure transducer/amplifier (13-4615-70, Gould, Cleveland OH, USA) and the 
flow signal was subsequently acquired and displayed in real time on a PC computer running 
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Spectra software (Grove Medical, London, UK) with 100 Hz analogue to digital sampling 
(PCI-MIO-16XE-50, National Instruments, Austin TX, USA).  Respiratory rate, inspiratory 
time (Ti) and the time to peak tidal expiratory flow were determined from the flow signal.  
Tidal volume was determined by digital integration of the flow signal by the acquisition 
software.  A constant flow of medical air from a cylinder was delivered to the inspiratory port 
of a two-way non-rebreathing valve via a length of wide bore (20mm), low resistance tubing.  
The inspired air could be enriched with a variable concentration of carbon dioxide (CO2) 
from a cylinder, the flow being controlled by a rotameter. Inspired and expired gases were 
sampled continuously using a small cannula inserted through the wall of the facemask and 
positioned close to the infant's mouth and measured using a capnography (CO2SMO 
capnography (Respironics UK, Chichester, UK).  The capnograph was calibrated with 
certified calibration gas (5% CO2/95% air, BOC Gases, UK) prior to each measurement. 
Inspired CO2 and end-tidal CO2 (ETCO2) levels were derived from the continuous capnogram 
recording, which was recorded simultaneously with respiratory flow and displayed in real 
time throughout the study.  Assessments were made at three levels of inspired CO2 (0% 
(baseline), 2% and 4%). The sequence for administering the level of inspired CO2 was 
randomised between each infant. Those levels were chosen to allow measurement of changes 
in respiration elicited by linear increases in the inspired CO2, without generating significant 
behavioural arousal and are in line with previous studies (Cohen and Henderson-Smart, 1994, 
Frantz et al., 1976).  Each mixture of CO2 was titrated and a stable inspiratory CO2 
concentration was achieved within the delivery tubing, as assessed by the capnograph 
readout, before the infant was connected to the breathing circuit.  The infant breathed the 
air/CO2 mixture for at least five minutes to allow ventilation and ETCO2 to reach steady state 
as assessed from the real-time display using the Spectra software (Grove Medical, London, 
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UK). There was a five minutes washout period between each level of inspired CO2 to ensure 
that the infant’s breathing returned to baseline 
The following outcomes were assessed with the hypercarbic challenge: 
1. Baseline respiratory rate, tidal volume, minute volume and time to peak tidal 
expiratory flow 
2. The percent change in minute ventilation related to the percent of inspired carbon 
dioxide 
3. The slope of the ventilatory response to hypercarbia, this is the gradient of the line of 
best fit of minute volume against the inspired CO2 level (Figure 2.3).  
4. The mean inspiratory flow (MIF) change was reported as the percentage increase 
from the baseline MIF to the MIF at 4% CO2.      
5. The time constant of the response to hypercarbia, defined as the time taken to achieve 








































Figure 2.2 Spectra recording during hypercarbic challenge 
 
The diagram illustrates the recording on spectra acquisition software during the hypercarbic 
challenge. The flow signal (top-black colour) was derived from the pneumotachograph. Tidal volume 
(Purple colour) was derived from digital integration of the flow signal and later adjusted for body 
weight. Inspired CO2 (Green colour) was derived from the capnography using a CO2 sampling line 
inserted through the facemask. During the study displayed above, the infant was switched from 
breathing 0% CO2 TO 4% CO2 for a period of 5 min. A five washout period was shown before the 
level of inspired CO2 was changed to 2%.The plethysmography wave shows represents the output 














Figure 2.3 The slope of ventilatory response to hypercarbia 
 
 
The slope of ventilatory response to hypercarbia determined by the gradient of the line of best 













Figure 2.4 Hypercarbic challenge outcomes. 
 
















2.4.2 Hypoxic challenge  
 
The hypoxic challenge was delivered via a facemask and custom-made open circuit system 
using 15% oxygen in balanced nitrogen from a cylinder (BOC Gases, UK). The facemask 
was placed over the infant’s mouth and nose; therapeutic putty was put around the rim of the 
facemask to ensure an airtight seal around the face. Respiratory flow was measured using an 
appropriately sized pneumotachograph connected to the facemask (Mercury F10L, G M 
Instruments, Kilwinning, Scotland) with a dead space 0.8 ml and a resistance of 0.86 
cmH2O/L/second.  The distal end of the pneumotachograph was connected to a two-way non-
rebreathing valve contained within the open circuit system.  A constant flow of medical air 
from a cylinder (BOC Gases, UK) was delivered to the inspiratory port of the two-way non-
rebreathing valve via length of wide bore (20mm), low resistance tubing. The 
pneumotachograph was attached to a differential pressure transducer/amplifier (13-4615-70, 
Gould, Cleveland OH, USA).  Data were acquired and displayed in real time on a PC 
computer running Spectra software (Grove Medical, London, UK) with 100 Hz analog to 
digital sampling (PCI-MIO-16XE-50, National Instruments, Austin TX, USA).  Tidal volume 
was determined by digital integration of the flow signal by the acquisition software.  Inspired 
and expired gases were sampled continuously using a small cannula inserted through the 
facemask and positioned close to the infant's mouth.  Oxygen saturation and heart rate were 
measured using a pulse oximeter (Masimo rainbow SET Pulse Oximetry). 
During quiet breathing, the infants were switched from breathing room air to 15% oxygen in 
nitrogen (BOC Gases, UK). The final minute of tidal breathing in air was used as the baseline 
value. The hypoxic challenge was maintained for five minutes, but terminated if the oxygen 
saturation level fell below 85%. Infants respond to hypoxia with a biphasic response (Figure 





1) The magnitude of increase in minute ventilation from baseline to the peak ventilation 
2) The magnitude of decline in minute volume from the peak to the lowest minute volume  
3) The change in the oxygen saturation level from baseline to the lowest oxygen saturation 
level. 
4) Magnitude of increase in heart rate from baseline to peak in response to hypoxic 
challenge  
5) Changes in end tidal CO2 (ETCO2) with hypoxia  
6) The rate of decline in minute volume, calculated as the peak minute volume-lowest 
minute volume divided by the time from peak to the lowest minute volume.  


















Figure 2.5  Spectra recording during hypoxic challenge 
The diagram illustrates the recording on spectra acquisition software during the hypoxic challenge. 
The flow signal (top-black colour) was derived from the pneumotachograph. Tidal volume (Purple 
colour) was derived from digital integration of the flow signal and later adjusted for body weight. 
ETCO2 (Green colour) was derived from the capnography using a CO2 sampling line inserted through 
the facemask. The infant was switched from breathing room air (arrow) to 15% oxygen for period of 
five-minutes. The plethysmography wave shows represents the output from the Masimo-set pulse 










Start of hypoxia  

















2.4.3 Equipment used for physiological measurements  
2.4.3.1 Measurement of flow  
 Flow was measured using an appropriately sized pneumotachograph (Mercury F10L, G M 
Instruments, Kilwinning, Scotland) with a dead space 0.8ml and a resistance of 0.86 
mmH2O/L/min inserted between the facemask a two-way non-rebreathing valve.  The 
pneumotachograph was attached to differential pressure transducer/amplifier (13-4615-70, 
Gould, Cleveland OH, USA) 
2.4.3.2 Calibration of the pneumotachograph 
Calibration of flow was carried out prior to each measurement. Flow was calibrated using a 
low flow rotameter (0-12 L/min Platon, Roxspur Measurement & Control Ltd, Bramley, 
Hants, UK). 
2.4.3.3 Linearity of system used to measure flow  
To assess pneumotachograph and pressure transducer linearity, air over a range of flows (1 to 
10 L/min) was passed through the pneumotachograph and the output plotted against the 
actual flow delivered by the rotameter. It had a linear response up to 10 L/min for both an 








2.4.3.4 Frequency response of the flow measurement system  
 Frequency response can be determined by a ‘pop test’ in which an inflated balloon is fitted 
over the signal input site and then burst, producing an instantaneous negative step input to the 
system. The frequency response of the system (f3db) is calculated using the equation f3db 
=1/3 x Tr, where Tr (response time) is defined as the time taken for pressure to fall from 90% 
to 10% of the initial pressure. The frequency response was determined using the pop test 
method, with the change in pressure against time recorded on a computer (MacBook, Apple 
Computer Corp, Cupertino, California, USA) using Chart software (Version 5.0, 
ADInstruments Pty Ltd, Bella Vista, NSW Australia) with analogue-to-digital sampling at 
40KHz (Powerlab, ADInstruments Pty Ltd, Bella Vista, NSW, Australia).  The frequency 
response of the flow measurement system (consisting of the pneumotachograph, connecting 
tubing, pressure transducer for flow, amplifier and computer) was determined by placing one 
end of the pneumotachograph within an inflated balloon. By partially occluding the other end 
of the pneumotachograph, a constant background flow was produced, during which the 
balloon was burst. The response time was 9 milliseconds, giving a calculated frequency 
response of 37 Hz.  
   










Inspired and expired gases were sampled continuously using a small cannula inserted 
through the wall of the facemask and positioned close to the infant's mouth, and measured 
using a capnograph (CO2SMO capnograph; (Respironics UK, Chichester, UK).  
2.4.4.1 Calibration of the capnography 
The capnography was calibrated with certified calibration gas (5% CO2/95% air, BOC 
Gases, UK) prior to each measurement.  
2.4.4.2 Linearity of exhaled carbon dioxide measurement 
 
To evaluate the linearity of the capnography various known concentrations of CO2 were 
connected the capnography. The acquired measured values were plotted against known 
concentration of CO2; this was observed to be linear for up to 10% CO2 concentration 
2.4.5 Masimo SET® Pulse Oximetry 
 
This is a noninvasive, arterial oxygen saturation and pulse rate monitor. The monitor features 
a backlit liquid crystal display (LCD) that continuously displays numeric values for SaO2 and 
pulse rate. It provides graphical display of plethysmographic waveform which is displayed 







2.4.6 Data acquisition and storage 
 
The data from the pnuemontacograph, capnography and the Masimo set monitor were   
transferred as a digital signal through a RS232 interface. The data was transferred to a PC 
computer which was preloaded with customised data acquisition software (Spectra, version 
3.0.1.4; Grove medical, London, UK). The Spectra software is a type of ‘digital chart 
recorder’ and is used to record signals from clinical transducers, patient monitors and life 
support equipment. In real time the software can capture, display and perform complex 
analyses and display the results. It can also mark events, replay and re-analyse data.  
Waveforms were recorded in real time, and displayed in graphical form. The display of 
recorded data was time-based; hence it was possible to review any period of interest. All 
datasets were stored with reference to a patient database, which can be reviewed and 












2.5 Sample size  
 
I aimed to assess 20 infants in each of the three groups completing assessments at 6-12 weeks 
of age as this sample size allowed detection of a difference of one standard deviation in each 
outcome measurement between the groups with 80% power at the 5% significance level. The 
magnitude of difference in the ventilatory response to added dead space between newborns of 
smoking and non-smoking mothers has been previously detected (Bhat et al., 2005). I 
assumed there would be a 50% drop-out rate between recruitment in the neonatal period and 















3 Maternal and infant urinary cotinine and 













3.1 Introduction  
 
The aims of the study were:  
- To validate maternal cigarette smoking practices using cotinine levels obtained in the 
immediate postpartum period  
- Compare smoking practices between mothers who substance-misused and smoked 
those who smoked only and between mothers who smoked tobacco and cannabis and 
those who smoked tobacco only  
- Describe the profile of substance misuse among mothers and infants  
 
3.2 Methods   
 
Antenatal substance-misuse profile of mothers in the SM group was reviewed. Details of the 
maternal methadone dose during pregnancy were obtained from the medical records for 
mothers on “prescribed” methadone.. Maternal smoking was defined as daily cigarette 
smoking regardless of the number smoked/day.  
3.2.1 Urine drug screen  
 
In the immediate postpartum period, urine samples were taken from the mothers and infants 
for drug screen. Urine samples were aliquoted and then stored at -20°C until assayed. 
Screening of the urines was carried out for cannabinoids, opiates, amphetamines, methadone, 






3.2.2 Cotinine analysis  
 
Maternal and infant’s urinary samples were tested for cotinine in the perinatal period. 
Cotinine reagent was supplied by Siemens Healthcare Diagnostics Ltd. The assay was a solid 
phase competitive chemiluminescence immunoassay for the measurement of cotinine in the 
urine as described in chapter 2. 
3.2.3 Statistical Analysis  
 
Data were tested for normality using the Kolmogorov-Smirnov test. Non-normally distributed 
data are presented as median (range). Linear regression analysis was used to assess the 
correlation between maternal cotinine levels; self-reported number of cigarettes smoked/day 
and infant’s cotinine levels. 
Man-Whitney U and Fisher Exact test were used to compare differences between infants of 
mothers who smoked only (S) and those who smoked and substance misused (SM) and 













3.3 Results  
 
140 maternal and infant’s urinary samples were screened for illicit drugs and cotinine in the 
perinatal period. Forty-nine mothers tested positive for cotinine with levels above the 
detection limit of 10ng/ml. Mothers smoked a median of 7 cigarettes/day range (2-20) (Table 
3.1). In the control group, twenty pairs of maternal/infant’s urinary samples were screened for 
cotinine with all the samples testing negative (cotinine below the detection limit of 10ng/ml). 
There was no significant correlation between maternal cotinine levels and the reported 
number of cigarettes smoked by the mother/day (R
2
=0.07) (Figure 3.1) and between maternal 
and infant’s cotinine (R2=0.138) (Figure 3.2) 
There were no significant differences in maternal cotinine, infant’s cotinine and the number 
of cigarettes smoked between S and SM mothers (Table 3.2). There were  also no significant 
differences in maternal cotinine, infant’s cotinine and the reported number of cigarettes 
smoked  by the mother between mothers who smoked both tobacco and cannabis and those 
who tobacco smoked only (Table 3.3). 
Analysis of urine samples in SM mothers during antenatal outpatient attendances confirmed 
that all SM women were substance misusing and misusing a wide range of substances (Table 
3.4). Urine drug screen in the postpartum period showed that twelve mothers were positive 
for methadone, seven were positive for cocaine and four were positive for benzodiazepines 
(Table 3.5). Three of the twelve mothers positive for methadone misused “non-prescribed” 
methadone and two mothers with history of cocaine misuse during pregnancy were negative 
for cocaine on postnatal urinary drug screen. Of the four-benzodiazepine positive mothers, 
three misused methadone and one was positive for cocaine in addition to the benzodiazepine. 




Table 3.1   Maternal and infant’s cotinine levels 
 

































 P value  
Cigarettes/day 10 (2-20) 6(3-20) 0.246 
Maternal cotinine 
(ng/ml) 
2330(65.9-5920) 1280 (39.7-18700) 0.552 
Infant’s cotinine 
(ng/ml) 
450.5(59.5-3300) 172.5 (39.5-8760) 0.496 
Birth weight 
(grams) 
















Table 3.3 Cotinine data by maternal cannabis smoking status 




cannabis smoking  
(n=27) 
 P value  
Cigarettes/day 6 (2-20) 7(3-20) 0.442 
Maternal cotinine 
(ng/ml) 
1595 (39.7-8940) 2330 (38.3-18700) 0.124 
Infant’s cotinine 
(ng/ml) 















Table 3.4 Results of the antenatal urine analysis of the substance misuse mothers 
 Number of 
subjects 
Mean  (SD) Range 
Visits to antenatal clinic and urine collected 20 9.33 (6.8) 1-26 
Number of occasions a particular substance was 
detected 
   
Methadone 13 6.86 (7.14) 0-26 
Illicit drug 20 6.95 (4.97) 1-20 
>1 illicit drug 17 3.95 (2.99) 1-19 
Ecstasy 6 0.90 (1.29) 0-5 
Cocaine 13 2.90 (2.84) 0-19 
Cannabis 11 4.24 (5.01) 0-18 
Morphine 11 2.19 (2.48) 0-20 
Any opioid metabolite 11 3.19 (3.68) 0-25 
Dihydrocodeine 5 0.52 (0.80) 0-3 
Benzodiazepines 6 0.90 (1.29) 0-6 
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Table 3.5 Methadone and cocaine data 
 
Maternal urine methadone level (ng/ml) 1723.5 (396-2460) 
Infant urine methadone level (ng/ml) 350 (16-1934) 
Maternal dose of methadone at delivery (mg) 50 (20-100) 
Maternal urine cocaine level (ng/ml) 1123 (332-1702) 
















































3.4 Discussion  
 
 
The results demonstrate a lack of correlation between reported maternal smoking and 
maternal urine cotinine levels obtained in the perinatal period suggesting mothers may not 
accurately report their smoking habits. On the other hand, all mothers and infants in the 
control group tested negative for cotinine and illicit drugs , which confirm that mothers in this 
group did not smoke or substance-misused. 
 Studies assessing the level of agreement between self-reporting of smoking and biochemical 
screening for smoking during pregnancy have provided conflicting results. Although some 
have found a correlation between self-reported smoking and biomarker measures (George et 
al., 2006, Kvalvik et al., 2012), others have demonstrated significant underreporting by the 
mothers (Lindqvist et al., 2002, Webb et al., 2003, Parna et al., 2005). In one study that 
compared the self-reports with serum cotinine in a national sample, 23% of pregnant smokers 
and 10% of non-pregnant smokers did not disclose their smoking habits (Dietz et al., 2011). 
In contrast, a recent study reported a high agreement between mothers’ self-reported smoking 
habits during pregnancy and their levels of serum cotinine (Mattsson et al., 2016). 
In addition, the results showed no significant correlation between maternal and infant’s 
cotinine levels. There was a time gap between the collections of maternal and infant’s urine 
samples for cotinine analysis. This may explain the lack of correlation between maternal and 
infant’s urinary cotinine levels. Indeed, trans-placental transfer of cotinine from pregnant 
mothers has been demonstrated in previous studies and was found to increase with advancing 
gestation (Jauniaux and Gulbis, 2001) 
In mothers who substance-misused and smoked, cotinine levels and smoking habits were 
similar to those who smoked only.  Similarly, maternal and infant’s cotinine levels did not 
differ between infants and mothers who smoked both cannabis and tobacco and those who 
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tobacco smoked only. Over half of the mothers who smoked in the study used tobacco and 
cannabis. Indeed, the use of cannabis and tobacco (primarily as tobacco cigarettes) frequently 
co-occurs as described in previous studies (Lynskey et al., 1998), (Degenhardt et al., 2001). 
In this study, all the mothers who substance-misused also smoked. The rates of nicotine use 
among abusers of illicit substances and alcohol are reported in the range of 85-100% (Bobo, 
1989, Burling and Ziff, 1988) (DiFranza and Guerrera, 1990). Hence nearly three times as 
many individuals with alcohol and drug problems smoke cigarettes compared to the general 
population. There is also evidence from previous studies that individuals who substance-
misuse tend to be heavy smokers (Hughes, 1995).Continued cigarette smoking has also been 
linked to worse substance abuse treatment outcomes (Frosch et al., 2000). Hence it is 
important to determine whether the effects of substance-misuse and smoking are additive on 







































4 Ventilatory response to hypercarbia in new-borns 
















4.1 Introduction  
 
Infants of mothers who smoked and/or substance misused during pregnancy have an 
increased risk of sudden infant death (SIDS) (Frosch et al., 2000, Ward et al., 1990, Kandall 
et al., 1993, Hoffman et al., 1988).   
 A possible explanation for the increased SIDS risk is that affected infants may have 
brainstem abnormalities which adversely affect their ventilatory control (Lewis and Bosque, 
1995) . If that explanation is correct, infants of mothers who smoked and/or substance 
misused during pregnancy would be predicted to have a reduced ventilatory response to 
hypercarbia. The aim of this study was to test that hypothesis by assessing the ventilatory 
response to hypercarbia of infants of substance misusing/smoking mothers, infants of 
smoking mothers and infants of non-substance misusing, non-smoking mothers. In addition, I 
tested the hypothesis that smoking and substance misuse would have an additive effect and 
hence any impairment of the ventilatory response to hypercarbia would be greater in new-
borns of mothers who both substance misused and smoked compared to those whose mothers 













Infants were eligible for entry into the study if they were born above a gestational age of 36 
weeks at King’s College Hospital NHS Foundation Trust and had no congenital 
abnormalities. Informed written parental consent was obtained and the study was approved 
by the Guys and St Thomas’s Hospitals NHS Foundation Trust Research Ethics Committee. 
Three groups were recruited: 
1. Infants of mothers with a history of substance misuse during pregnancy (SM infants) 
2. Infants of mothers with a history of smoking during pregnancy (S infants). 
3. Infants of mothers who neither smoked nor misused substances during pregnancy 
(Controls). 
4.2.1 Hypercarbic challenge 
 
The hypercarbic challenge was delivered via a facemask and pneumotachograph through a 
Custom-made open circuit system with individually adjustable flows of carbon dioxide (CO2) 
and air (see Methods chapter 2).  
The ventilatory responses to three levels of inspired carbon dioxide (0% (baseline), 2% and 
4% CO2) were assessed 
The following outcome measures were assessed: 
1. Baseline respiratory rate, tidal volume, minute volume and time to peak tidal 
expiratory flow 
2. The percent change in minute ventilation related to the percent of inspired CO2 
3. The slope of the ventilatory response to hypercarbia, the gradient of the line of best fit 
of minute volume against inspired CO2. 
4. The mean inspiratory flow (MIF) change: the percent increase from the baseline MIF 
to the MIF at 4% CO2. 
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4.2.2 Assessment of exposure to smoking and substance misuse 
 
In the immediate postpartum period urine samples were obtained from all mothers and infants 




Differences between the three groups were tested using the Kruskal Wallis analysis of ranks 
test for continuous data or the chi-squared test for binary data. Differences in the respiratory 
results between groups were assessed using regression analysis. Data were transformed using 
a logarithm or square root transformation to meet regression assumptions. Adjustment was 
made for baseline differences in birthweight, gestational age, head circumference and gender 
by fitting the variables as covariates. Results are presented as unadjusted and adjusted 
arithmetic means (normal data or square root transformed data) or geometric means (log-
transformed data). Adjusted means are marginal estimates set to the mean value of the 
covariates. Analyses were conducted using Stata version11. 
4.2.4 Sample size 
 
The aim was to recruit at least 20 infants in each of the three groups to detect a difference 
equivalent to one standard deviation in each outcome measurement between the groups with 
80% power at the 5% level. A similar magnitude of difference had been detected in the 
ventilatory response to added dead space between newborns of smoking and non-smoking 





4.3 Results  
 
Twenty-two SM, 34 S and 22 control infants were assessed (Table 4.1). The median birth 
weight of the controls was significantly higher than the SM and S infants (p=0.015). The 
urine analyses demonstrated that all the SM and S mothers had smoked during pregnancy, but 
none of the mothers of the controls had smoked. There were no significant differences in the 
proportion of either infants or mothers in the groups with elevated cotinine levels between the 
S and SM groups (Table 4.2). Analysis of urine samples during antenatal visits confirmed 
that all SM women were substance misusing. The women were taking cocaine, cannabis, 
morphine, dihydrocodeine, heroin and/or benzodiazepines. In the SM group, urine analyses in 
the immediate post-partum period demonstrated five of the twelve women who had been 
prescribed methadone were also taking it illicitly. Analyses of urine samples in the neonatal 
period confirmed all SM women had been substance misusing, but that none of the S women 
or controls had substance misused. 
There were significant differences in the mean baseline respiratory rate and minute volume 
between the groups and these differences remained of similar size and statistical significance 
after adjustment for baseline neonatal factors. Both the S and SM infants had significantly 
greater results than the controls (Table 4. 3). The mean time to peak tidal expiratory flow was 
significantly lower in the SM and S infants than in the controls (Table 4.3). Both the SM and 
S infants had lower ventilatory responses to 2% (p<0.001) and 4% (p<0.001) CO2 than the 
controls and the differences were not affected by adjustment for neonatal factors (Table 4.3). 
The ventilatory response to CO2 was lower in the SM compared to the S infants (p=0.009). 
The mean slope of the ventilatory response was significantly lower in the SM and S infants 
than the controls (p<0.0001) (Table 4. 4) (Figure 4.1). The percentage changes in MIF were 
significantly lower in the SM and S infants than the controls (p<0.0001) (Table 4. 4) and 
lower in the SM compared to the S infants (p=0.005) (Figure 4.2). 
90 
 
Table 4.1 Demographic data demonstrated as median (range) or n (%) 
               
Control 
     
S 





22 34 22  
Gestational age (wks) 39 (36-42) 39 (36-41)  37 (36-41)  0.12 
Birth weight (grams) 3276(2500-4320)  2866(1824-4460) 2844 (1860-3342)  0.015 
Head circumference 
(cm) 
34 (32- 37)  34 (30-37)
 
33 (30-35) 0.048 
Gender (male) 14 (63.6%) 22(64.7%) 9 (40.9%) 0.17 
Age at study (days)  2 (1-5)  2 (1-9)  2 (1-9) 0.36 
















Table 4.2   Urinary cotinine levels in the smoking and substance misuse groups 
   S  SM 
Maternal urine cotinine  





       10-500ng/ml 40% 24% 
        > 500ng/ml 60% 76% 
Infant urine cotinine  





       10-500ng/ml 73% 56% 











Table 4.3   Baseline tidal breathing results and the percentage change in minute volume 
with 2% and 4% inspired CO2 by maternal smoking and substance misuse status 
 






















43 (11; 29-73) 
43 (39, 47) 
 
 
49 (12; 36-80) 
50 (46, 54) 
 
 
54 (12; 35-81) 

















7.2 (6.7, 7.8) 
 
6.9 (1.5; 4-10) 
6.6 (6.1, 7.0) 
 
7 (1.3; 4.9-9.3) 



































































% change in minute 










59 (50, 69) 
 
 
31 (17; 3-74) 
31 (23, 38) 
 
 
24 (21; 0-75) 




% change in minute 

















66 (55, 76) 
 
 
44 (25; 4-91) 









 denotes that all means are geometric means due to skewness of the distribution  
2
 SD: standard deviation on natural scale 
3
 denotes marginal means adjusted for birthweight, gestational age, head circumference and 




Table 4.4 The slope of the ventilatory response and the percentage change in mean 












Slope of the ventilatory 
response 
(ml/kg/min/%)-1 
    










82 (72, 91) 
56 (23; 19-
113) 
57 (50, 65) 
40 (21; 3.5-97) 
35 (26, 45) 
<0.0001 
<0.0001 
Percentage change in 
mean inspiratory flow 
(MIF)  
    





















SD: Standard deviation on natural scale  
 
2 
denotes marginal means adjusted for birthweight, gestational age, head circumference and 
gender (set to mean values) 
3
 The analysis was conducted using square root transformation, unadjusted and adjusted 
means are therefore untransformed; 95% CIs cannot be calculated. P values are from the 
transformed analyses. Adjusted values are marginal means adjusted for birthweight, 




























4.4 Discussion  
 
These results demonstrate that infants of both smoking and substance-misusing/smoking 
mothers have a dampened ventilatory response to hypercarbia in the immediate newborn 
period compared to controls; in addition the ventilatory response was poorer in the SM 
compared to the S infants. There was also lower increase in central respiratory drive, as 
assessed by the mean inspiratory flow (MIF), in infants of smoking and substance-
misusing/smoking mothers compared to the controls. Infants of substance-misusing mothers 
or smoking mothers have been previously shown to have a reduced carbon dioxide sensitivity 
(Wingkun et al., 1995) . To my knowledge, this is the first study that has compared the 
responses to hypercarbia in infants of substance-misuse/smoking mothers and infants of 
smoking mothers. Infants exposed to methadone in-utero compared to controls have been 
demonstrated to have decreased sensitivity to a carbon dioxide challenge as measured by the 
slope of the ventilatory response curve during the first weeks after birth (Olsen and Lees, 
1980). The depressed ventilatory response to carbon dioxide lasted on average for 15 days 
after birth (Olsen and Lees, 1980).  It was not possible to assess the effect of methadone per 
se on the infants’ ventilatory responses, as the majority of the mothers from the substance-
misuse group were misusing multiple drugs during pregnancy. In addition, as all of the 
substance misuse mothers smoked, it was not possible to separate out the effects of antenatal 
substance misuse and smoking. The results, however, suggest that smoking and substance 
misuse during pregnancy may have an additive adverse effect on the response to hypercarbia. 
Studies examining infant responses to hypercarbia in relation to maternal smoking have 
yielded conflicting results  (Lewis and Bosque, 1995), (Galland et al., 2003) . In one study no 
difference was found between the ventilatory and awakening responses to hypercarbia at two 
to three months of age in infants of smoking mothers compared to controls (Lewis and 
Bosque, 1995). In another study an increase in the ventilatory response of a combined 
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hypercarbic/hypoxic challenge in small for gestational infants of smoking mothers compared 
to controls was demonstrated when the infants were between one to three months of age. In 
both of those studies (Lewis and Bosque, 1995), (Galland et al., 2003) the infants could have 
been exposed postnatally as well as antenatally to maternal smoking.  In this study infants 
were studied prior to maternity/neonatal unit discharge and thus were specifically assessed 
the effect of antenatal exposure to maternal smoking. The results are consistent with the 
findings from pervious study which showed that infants of mothers who smoked antenatally 
and were studied prior to maternity unit discharge had a dampened ventilatory response to 
added dead space, in which the major stimulus is hypercarbia when compared to controls 
(Bhat et al., 2005).  
There are strengths and some limitations to this study.  Maternal report was not relied on to 
categorise which group an infant belonged, all the mothers’ and infants’ urine samples 
analysed postnatally as well as analysis of the SM mothers’ urine samples antenatally. The 
infants’ response to the hypercarbic challenge was assessed in a number of ways and 
demonstrated consistent findings. There were significant differences in baseline 
characteristics, but the results remained statistically significant after adjusting for those 
baseline differences. At baseline, the SM and S infants differed with regard to their 
respiratory rate, minute volume and time to peak tidal expiratory flow. The differences 
demonstrated with regard to time to peak tidal expiratory flow are consistent with previous 
findings, that is a shortened time to peak expiratory flow had been demonstrated in infants of 
mothers who smoked antenatally compared to controls (Hoo et al., 1998). The higher 
respiratory rate and minute volume of the SM and S infants at baseline may reflect 
withdrawal from substances (including nicotine) misused by their mothers. Despite the 
differences in minute volume at baseline, significant differences in the response to increasing 
levels of CO2 were demonstrated between the three groups. The higher baseline minute 
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volumes of the SM and S infants may explain in part their lower respiratory response to 
hypercarbia.  The controls, however, compared to the SM and S infants achieved significantly 
higher minute volumes in response to hypercarbia emphasizing that regardless of the baseline 
differences the SM and S infants had a dampened response. 
In conclusion, infants of both smoking and substance-misusing/smoking mothers compared 
to controls had a dampened response to a hypercarbic challenge in the newborn period. The 
infants of mothers who substance abused and smoked during pregnancy had a more 
dampened response than the infants of mothers who only smoked. The results are compatible 
with dampened chemoreceptor function in infants exposed in utero to smoking and substance 
misuse. If that abnormality persists beyond the neonatal period, it may explain the increased 






















5 Antenatal substance misuse and smoking and 















5.1 Introduction   
 
In utero exposure to illicit drugs such as opioids, marijuana and cocaine is associated with an 
increased risk of sudden infant death syndrome (SIDS) (Ward et al., 1990). A possible 
explanation for the increased SIDS risk is that infants of SM or S mothers may have 
abnormalities of respiratory control.  There is a body of evidence demonstrating nicotine 
exposure could and does influence respiratory control in animal models.  For example, 
prenatal exposure to nicotine may alter the function of peripheral chemoreceptors, as in three-
day old rabbit pups exposure to nicotine was associated with reduced dopamine levels and 
increased expression of tyrosine hydroxylase in the carotid bodies (Holgert et al., 1995). The 
ventilatory responses to hypoxia has been demonstrated to be attenuated by infusion of 
nicotine to 7, 17 and 27 day old lambs.(Milerad et al., 1995). Furthermore, nicotine infusion 
to pregnant rats throughout gestation resulted in the pups having suppressed noradrenergic 
neuronal activity in the brainstem and forebrain and hyperresponsiveness to hypoxia.(Slotkin 
et al., 1995). In addition, intermittent hypoxia was demonstrated to result in transient delay in 
neuronal migration early in the postpartum period in Spragne-Dawley rats, amplified by 
concurrent nicotine administration.(Zechel et al., 2005) Data from in vivo studies have 
highlighted that in utero exposure to substance misuse may also affect respiratory control.  
Infants prenatally exposed to cocaine were demonstrated to have a higher incidence of 
cardiorespiratory pattern abnormalities than infants with no prenatal drug exposure.(Chasnoff 
et al., 1989) In another study, full term infants prenatally exposed to cocaine and opiates had 
less periodic breathing (Silvestri et al., 1991). Even apparently asymptomatic neonates with a 
maternal history of cocaine use may have degenerative changes or focal infarctions in their 
basal ganglia (Dogra et al., 1994). Infants of mothers who smoked and/or substance misused 
during pregnancy may therefore have a poor ventilatory response to hypoxia.  The aim of this 
study was to test that hypothesis by comparing the ventilatory responses to hypoxia of infants 
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of substance misusing mothers, infants of smoking mothers and infants of non-substance 
misusing, non-smoking mothers.  In addition, a further hypothesis was tested that any change 
in the ventilatory response to hypoxia would be greater in newborns of mothers who 
substance misused, as such mothers usually also smoke, compared to those whose mothers 
had only smoked. 
 
5.2 Methods    
 
Infants were eligible for entry into the study if they were born at 36 weeks of gestational age 
or greater at King’s College Hospital NHS Foundation Trust and had no congenital 
abnormalities. Informed written parental consent was obtained and the study was approved 
by the Guy’s and St Thomas’s Hospitals NHS Foundation Trust Research Ethics Committee.   
Three groups were recruited: 
1. Infants of mothers who gave on antenatal screening a history of substance misuse 
during pregnancy (SM infants). 
2. Infants of mothers who gave on antenatal screening a history of smoking during 
pregnancy (S infants).  








5.2.1 Hypoxic challenge  
 
The hypoxic challenge was delivered via a facemask and custom-made open circuit system 
using 15% oxygen, as described in Chapter two. 
During quiet breathing, the infants were switched from breathing room air to 15% oxygen in 
nitrogen. The final minute of tidal breathing in air was used as the baseline value. The 
hypoxic challenge was maintained for five minutes, but terminated if the oxygen saturation 
level fell below 85%. Infants respond to hypoxia with a biphasic response (Cohen et al., 
1997) .  
The responses to the hypoxic challenge were determined by: 
1) The magnitude of increase in minute ventilation from baseline to the peak 
ventilation 
2) The magnitude of decline in minute volume from the peak to the lowest minute 
volume  
3) The rate of decline in minute volume, calculated as the peak minute volume-lowest 
minute volume divided by the time from peak to the lowest minute volume.  
4) The change in the oxygen saturation level from baseline to the lowest oxygen 
saturation level. 
The time to peak minute ventilation was noted; as was the time to the lowest SaO2 and the 






5.2.2 Assessment of exposure to smoking and substance misuse 
 
In the immediate postpartum period, urine samples were obtained from all mothers and 




Differences between the three groups for continuous data were assessed for statistical 
significance using multiple regression where possible, with data transformation as needed to 
meet normality assumptions, if that was not possible the Kruskal-Wallis analysis of ranks test 
was used. Differences in baseline minute volume, the increase and decrease in minute volume 
were adjusted for gestational age using multiple regression on the transformed outcomes. The 
increases in minute volume data were highly skewed and so a square root transformation was 
required to satisfy Normality assumptions. Since back-transformed confidence intervals are 
non-interpretable for square root-transformed data, p values are reported using the 
transformed data for rigour, but means and confidence intervals are presented on the natural 
scale.  For data that could not be transformed, post hoc comparisons were conducted using 
the Mann Whitney-U test (continuous data) or Chi squared test (categorical data).  Where 
regression analysis was used, post hoc comparisons were made using likelihood ratio tests.  







5.2.4 Sample size 
 
Recruitment of 20 infants in each of the three groups allowed detection of a difference 
equivalent to one standard deviation in each outcome between the groups with 80% power at 
the 5% level. A similar magnitude of difference had been detected in the ventilatory response 
to added dead space between newborns of smoking and non-smoking mothers.(Bhat et al., 
2005) 
 
5.3 Results  
 
Twenty-one substance-misuse (SM), 21 smoking (S) and 19 control infants were assessed 
(Table 5.1). The mean gestational age of the infants varied significantly between the three 
groups: SM infants were of significantly of lower mean gestational age than the S infants and 
the controls Similarly mean birth weight varied significantly between groups, the mean birth 
weight of the SM infants was lower than that of the S infants and the controls The urine 
analysis demonstrated that all the mothers of SM infants were also smoking, but that none of 
the mothers of the controls were smoking (Table 5.2). The urine analysis also demonstrated 
none of the mothers of S infants or the controls had been substance misusing.  There were no 
significant differences in the percentage of mothers or infants with cotinine levels in 
predefined categories between the S and SM groups (Table 5.2). In the SM group, urine 
analysis in the immediate post-partum period demonstrated five of the 10 women who had 
been prescribed methadone were also taking it illicitly.  
 
There was significant variability between the groups in mean baseline minute volume, which 
remained significant after adjustment for gestational age (Table 5.3).  The SM infants had a 
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significantly higher adjusted mean baseline minute volume than controls (395 vs 348; 
p=0.005) (Table 5.3).  The initial increase in minute volume during the hypoxic challenge 
differed significantly between the groups before and after adjustment for gestational age, 
there was a significantly higher mean increase in the SM group compared to the S group (117 
vs 57; p=0.028) and the controls (p=0.034) (Table 5.3). The magnitude of the subsequent 
decline in minute volume varied significantly between the groups with a greater magnitude of 
decline occurring in the SM compared to the controls (220 vs 106; p<0.001) and the S infants 
(220 vs 151; p=0.018).   The mean rate of decline in minute volume also varied significantly 
between the groups overall and was greater in the SM infants compared to the controls (4.29 
vs 160; p=0.008) and the S infants compared to the controls (4.29 vs 3.88; p=0.011) (Figure 
5.1). There were no significant differences in either the mean baseline oxygen saturation or 
mean lowest saturation level in response to the hypoxic challenge between the groups (Table 
5.4). The mean time to the lowest oxygen saturation, however, was greater in the controls 
compared to both the infants of S or SM mothers (115, 100, 100 seconds respectively; 
p=0.017) (Table5. 4).  There were no significant differences in the mean time of peak minute 
ventilation or the maximum baseline end tidal CO2 levels between the three groups (Table5. 
4).  It was noted, however, that the capnogram results often did not return to zero baseline on 











Table 5.1 Demographics by maternal smoking and substance misuse status 
 Controls  
(n=19) 
Smoking (S)   
(n=21) 













0.01 S versus control: 0.77 
SM versus S: 0.02 
SM versus control: 0.007 







0.002 S versus control: 0.41 
SM versus S: 0.02 
SM versus control: 0.003 
Head circumference (cms) 34.2 (1.5) 
[35; 32-37] 














58% (11) 71% (15) 43% (9) 0.17  
Mode of delivery (SVD) 23% (11) 40% (19) 36% (17) 0.06  
Age at study (days ) 2 (1-5) 2( 1-9) 2(1-8) 0.35  
 







Table 5.2 Urinary cotinine data by maternal smoking and substance misuse status 
   S  SM 
Maternal urine cotinine <10ng/ml 0% 0% 
       10-500ng/ml 40% 23.5% 
        > 500ng/ml 60% 76.5% 
Infant urine cotinine  





       10-500ng/ml 73% 56% 
       > 500ng/ml 27% 44% 
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Table 5.3   Changes in minute ventilation by maternal smoking and substance misuse status 
 Unadjusted values 
mean; median (range) 
Adjusted for gestational age
1 
Mean (95% CI) 
















Overall P  




317; 317  
(203-405) 
354; 344  
(253-524) 












S versus control: 0.16 
SM versus control: 0.005 




 44; 37 
(0-126) 
55; 45  
(0-163) 












S versus control: >0.99 
SM versus control: 0.034 





100;  102  
(15-233) 
147; 129  
(54-243) 
230; 225  
(56-444) 







S versus control: 0.038 
SM versus control: <0.001 
SM versus S: 0.018 
 


















S versus control: 0.011 
SM versus control: 0.008 
SM versus S: 0.77 
 
1 
Note: adjusted estimates for Increase in minute volume and magnitude of decline in minute volume are calculated from untransformed data as confidence 
intervals based on square root transformed data cannot be back-transformed. Significance tests are from transformed data  
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Baseline SpO2 (%) 
 
99 (96-100) 99 (97-100) 100 (96-100) 0.81 
Lowest SpO2 (%) with hypoxic 
challenge 
 
88 (85-94) 88 (85-94) 87 (85-96) 0.65 
Time to lowest SpO2 (seconds) 
 
115 (60-300) 100 (50-160) 100 (30-200) 0.017 
Change in SpO2 (%) 10 (5-15) 10 (6-15) 11 (4-15) 0.66 
Time to peak minute ventilation 
(seconds) 
94 (10-282) 115 (35-256) 135 (35-286) 0.177 
Maximum baseline end tidal CO2 35 (27-41) 33 (26-42) 31 (27-38) 0.21 
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Figure 5.1 Magnitude of decline in minute volume with hypoxia by maternal smoking 














5.4 Discussion   
 
These results demonstrate that infants of SM mothers had a greater magnitude of decline in 
ventilation than the controls and S infants and both the SM and S infants had a greater rate of 
decline in minute ventilation compared to controls.  The three groups’ gestational ages 
differed significantly and, as maturity at birth affects respiratory control, adjustment was 
made for differences in gestational age.  Similar significant differences were found after that 
adjustment.  Similarly, differences in the initial increase in minute ventilation between the 
three groups remained significant after adjustment for gestational age.  To my knowledge, 
this is the first study that has compared the responses to hypoxia in neonates of substance-
misuse/smoking mothers and smoking mothers.  The results suggest in utero exposure to 
substance abuse and smoking have an additive effect on the response to a hypoxic challenge 
and may explain their increase risk of SIDS.  
The early excitatory phase of the biphasic ventilatory response to hypoxia is the result of 
peripheral chemoreceptor stimulation. It is mediated through N-methyl-D-aspartate (NMDA) 
glutamate receptors in the caudal brainstem.  Prematurely born infants with neonatal apnoea 
were shown to have an increased ventilatory response to hypoxia.(Nock et al., 2004).  
Reduction in arterial oxygen tension strongly stimulates the carotid bodies, which mediate the 
rapid increase in ventilation.  The authors (Nock et al., 2004), therefore, speculated that 
previous episodes of apnoea with resultant intermittent hypoxia led to the enhanced 
peripheral chemoreceptor response to hypoxia.  The peripheral chemoreptors are active from 
at least 28 weeks of gestation (Rigatto et al., 1975). Fetuses exposed to nicotine and other 
misused substances are exposed to intermittent/chronic hypoxia in utero which may explain 
the initial increased ventilatory response to hypoxia observed in this study (Suzuki et al., 
1980).  The study results demonstrating infants of misusing/smoking mothers had a greater 
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initial increase in ventilation are supported by the finding that infants who were chronically 
exposed in utero to opiates had a significantly greater initial ventilatory increase to hypoxia 
compared to non-opiate exposed controls.(Teichtahl et al., 2005) 
Exposure to intermittent chronic hypoxia may explain my findings. Compared to controls, 
there was a greater rate of decline in the ventilatory response to the SM and S infants and a 
greater magnitude of decline in the SM infants.  In a piglet model, the decline was more 
marked following exposure to chronic intermittent hypoxia until day ten after birth (Miller et 
al., 2000) as evidenced by a decline in phrenic electroneurograms (ENGphr). Several 
neurotransmitters including -aminobutyric acid (GABA) (Martin et al., 2004), adenosine 
(Richter et al., 1999), (Neylon and Marshall, 1991), serotonin (Simakajornboon and 
Kuptanon, 2005) and opioids (Kato et al., 2000) are involved in the late component of the 
hypoxic ventilator response.  Intracisternal injection of bicuculline, a GABAA antagonist, in 
piglets aged two to ten days old reversed the effects of recurrent hypoxia on the ENGphr 
hypoxic response and eliminated apnoea during hypoxia (Miller et al., 2000). The authors, 
therefore, speculated that in the newborn period, GABA is released within the brainstem in 
direct proportion to the number of episodes of recurrent hypoxia, resulting in activation of 
GABAA receptors and worsening of hypoxic respiratory depression (Miller et al., 2000). The 
late phase is mediated in part through platelet derived growth factor (PDGF) foreceptors 
maturation of the neuromodulators, particularly NMDA and PDGF-β Receptors mediated 
pathways occurs during the postnatal period (Simakajornboon and Kuptanon, 2005). 
This study has strengths and some limitations. Infants were studies prior to 
maternity/neonatal unit discharge and thus I was able to assess the effect of only the antenatal 
exposure to smoking and illicit substances.  I assessed substance misuse by analysing samples 
from the mothers and their infants and cotinine levels were also measured, hence 1 had an 
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objective evidence of substance misuse and antenatal smoking.  I was unable to assess the 
effect of substance misuse alone as all the mothers from the substance-misuse group smoked.  
In addition, I was unable to assess the effect of specific drug misuse as the majority of 
mothers were misusing multiple drugs. I did not find any significant differences between the 
groups in the lowest saturation level in response to the hypoxic challenge, but this is likely 
because the challenge was terminated if the oxygen saturation level fell below 85%.  The 
oxygen saturation level did not fall below 85% in all infants, hence I compared the time to the 
lowest oxygen saturation level in the three groups.  The time taken to reach the lowest SaO2 
was significantly longer in the controls compared to either infants in the S or SM groups, 
likely reflecting the latter two groups had a greater magnitude of decline in ventilation than 
the controls.  A sidestream method was used to measure ETCO2 levels using a CO2 sampling 
line and capnograph. The sidestream method does not adequately monitor both nasal and oral 
airflow. When the capnographic waves were examined, it was often noted that capnogram 
trace did not return to zero baseline on inspiration which may have influenced some of the 
results. Given the method we used to measure ETCO2, it was not possible to evaluate the 
changes in ETCO2 at different periods during the hypoxic challenge. The differences in the 
maximum baseline ETCO2 levels were not statistically significant, but there was a trend for 
the S infants to have lower levels than the controls and the SM infants lower levels than the S 
infants.  This trend likely reflects the significantly higher baseline minute volumes in the SM 
infants compared to the controls and the trend for the SM infants to have higher baseline 
minute ventilation than the S infants and the S infants to have higher levels compared to the 
controls. The infants of substance misusing mothers had higher baseline minute ventilation 
than the other two groups, reflecting they were withdrawing from the substances their 
mothers had misused.  Nevertheless, I was able to show a significant difference in the 
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response of the SM infants to the hypoxic challenge compared to both the controls and the S 
infants.    
In conclusion, both SM and S infants compared to controls had a greater rate of decline in 
ventilation as well as a greater increase in ventilation in response to a hypoxic challenge in 
the newborn period. The results also highlight that SM infants had a greater magnitude of 
decline in ventilation than the S infants or the controls suggesting that substance misuse and 









6 Ventilatory responses to hypercarbia in infants of 
smoking and substance-misusing mothers at the peak 

















6.1 Introduction  
 
Sudden infant death syndrome (SIDS) remains a major cause of death in infants less than one 
year of age in developed countries (Mathews and MacDorman, 2013). Risk factors for SIDS 
include maternal smoking (Mitchell et al., 1997) and substance misuse (Mitchell et al., 1997) 
(Blair et al., 1996).  
Studies in the neonatal period before maternity unit discharge (chapter 4), demonstrated that   
infants of smoking and substance-abusing mothers have a dampened ventilatory response to 
hypercarbia compared to controls. In addition to that, there was an additive effect of 
substance-misuse since the impairment of the ventilatory response to hypercarbia was more 
marked in SM infants whose mothers also smoked compared to S infants (chapter 4).  
I have, therefore, hypothesized that infants of substance misusing mothers and infants of 
smoking mothers would have a poorer ventilatory response to hypercarbia compared to 
infants of non– substance misusing, non-smoking mothers at the peak age of SIDS (post term 
6-12 weeks) and that smoking and substance misuse would have an additive effect, such that 
any impairment of the ventilatory response to hypercarbia would be greater in infants of 
mothers who both substance misused and smoked.  The aims of this study were to test those 
hypotheses and determine if the dampening of the response was greater in the peak age for 









6.2 Patients and methods  
 
Infants were eligible for entry into this study if they were born with a gestational age of 
greater than 36 weeks at King’s College Hospital NHS Foundation Trust and had been 
assessed in the neonatal period before maternity unit discharge.  
Three groups of infants completed the follow up studies at 6-12 weeks of age: 
4. Infants of mothers with a history of substance misuse during pregnancy (SM infants) 
5. Infants of mothers with a history of smoking during pregnancy (S infants).  
6. Infants of mothers who neither smoked nor misused substances during pregnancy and 
the postpartum period (controls). 
 
6.2.1 Hypercarbic challenge  
 
Hypercarbic challenge was delivered via a facemask and pneumotachograph through a 
custom-made open circuit system with individually adjustable flows of carbon dioxide (CO2) 
and air.  The ventilatory responses to three levels of inspired carbon dioxide (0% (baseline), 
2% and 4% CO2) were assessed (see Methods Chapter 2). 
The following outcomes were assessed: 
1.    Baseline respiratory rate, tidal volume, minute volume and time to peak tidal expiratory 
flow 
2 The percent change in minute ventilation related to the percent of inspired carbon dioxide 
3 The slope of the ventilatory response to hypercarbia, this is the gradient of the line of best 
fit of minute volume against the inspired CO2 level. 
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4 The mean inspiratory flow (MIF) change was reported as the percentage increase from 
the baseline MIF to the MIF at 4% CO2. 
5 The time constant of the response to hypercarbia, defined as the time taken to achieve 
63% of the maximal response to 4% CO2 
 
6.2.2 Statistical analysis 
 
Differences between in the three groups were assessed for statistical significance using the 
Kruskal-Wallis one-way analysis of variance or Chi-square as appropriate.  Differences 
between results in the neonatal period and 6-12 weeks of age were assessed for statistical 
significance using the paired Wilcoxon rank sum test. Analysis was performed using SPSS 
version 22.0 (SPSS, Inc., Chicago, IL). 
 
6.2.3 Sample size  
 
78 infants were recruited in the neonatal period, with at least 20 infants in each of the three 
groups.  That sample size allowed us to detect a difference between each of the three groups 
equivalent to one standard measurement with deviation in each outcome of 80% power at the 







6.3 Results  
 
Forty-four of the 78 infants assessed in the neonatal period completed the follow-up studies at 
6-12 weeks of age. There were no significant differences in the gestational age at birth, birth 
weight, gender and mode of delivery or maternal age between those who did and did not 
complete the follow- up studies (Table 6.1). Of the 34 infants who did not complete the 
follow-up studies, some were lost to follow up and others were unable to perform the 
measurements. Of the 44 infants who completed the follow -up study, there were no 
significant differences in their weight or age at the time of the study, between the groups 
(Table 6.2).  The cotinine analysis in the neonatal period demonstrated that all the SM 
mothers and the S mothers were smoking and none of the controls were smoking.  In the SM 
group, eight women were taking prescribed methadone and two cocaine, five mothers 
misused multiple drugs. 
There were no significant differences in the baseline respiratory rate, tidal volume and minute 
volume between the groups (Table 6.3). The mean time to peak tidal expiratory flow was 
significantly shorter in the SM and S infants than the controls (Table 6.3). There was an 
increase in minute volume in response to breathing 2% and 4% CO2 in all the groups. Both 
the SM and S infants had a lower ventilatory response to 2% (p<0.001) and 4% (p<0.001) 
CO2 than the controls (Table 6.3). The slope of ventilatory response to CO2 was greater in the 
controls than the SM and S infants (p=0.001) (Table 6.4) (Figure 6.1) and lower in SM 
infants compared to S infants (p=0.04). The percentage change in MIF was greater in the 
controls than the SM or S infants (p=0.001) (Table 6.4) (Figure 6.2) and lower in SM 
compared to S infants (p=0.03). The time constant of the response to CO2 was longer in the S 
and SM infants compared to controls (p=0.001) (Table 6.4) (Figure 6.3) and longer in SM 
compared to S infants (p=0.04).  The percent increases in minute volume at 2% CO2 
(p=0.003) and 4% CO2 (p < 0.001) and the slope of ventilatory response to CO2 (p< 0.001) 
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Table 6.1 Comparison of the infant demographics and age of their mothers who did and 
did not complete the follow up study 
 Follow up completed  
(n=44) 
No follow up  
(n=34) 
P value  


















35 (80%) 23 (66%) 0.165 






Table 6.2 Demographic data at follow up by substance misuse and smoking status 
N Control (14) S (15) SM (15) p value 
Weight (kg) 4.93 (3.66- 6.68) 4.95 (4-6.5) 4.5 (3.5-5.68) 0.312 
Gender (male) 6 (43%) 11(73%) 7 (47%) 0.194 
Maternal age (years) 29 (20-37) 30 (20-43) 30 (20-40) 0.878 





















Table 6.3   Baseline tidal breathing results and percentage change in minute volume 
with 2% and 4% inspired CO2 by maternal smoking (S) and substance misuse (SM) 
status 
N Control 14 S 15 SM 15 p value 
Respiratory rate, breaths/min 43 (30-70) 44 (26-62) 47 (32-65) 0.524 
Tidal volume ml/kg 7 (5-9.4) 7.3 (5.3-9.5) 7(3.3-9.1) 0.861 
Minute volume ml/kg/min 280 (200-560) 301 (210-411) 322 (210-415) 0.073 
Time to peak tidal expiratory 
flow (seconds) 





Baseline mean inspiratory 
flow  
10 (6-21) 11 (8-17.7) 11.1 (5.5-17) 0.144 
% Change in minute volume 
at 2% CO2 
45.9 (19-93.3) 23.6 (10.3-
36.7) 
16.7 (7.9-45.5) < 0.001 
% Change in minute volume 










Table 6.4 The slope of the ventilatory response and the percentage change in mean 
inspiratory flow to the Hypercarbia by maternal smoking (S) and substance misuse 
(SM) status 
N Control (14) S (15) SM (15)   p value 
Slope of the ventilator 
response  
(Ml/kg/min/%) 
48.3 (22.5-70) 33.7 (24-46.8) 28.8 (18.3-
47.8) 
0.001 
Percentage change in mean 






















Table 6.5 The ventilatory responses to hypercarbia in the neonatal and 6-12 weeks of 
age 
 Neonatal (n=78) 6-12 weeks (n=44) p value 
 






































Figure 6.1  Box and whisker plot of slope of the ventilatory response to hypercarbia by 


















Figure 6.2  Box and whisker plot of the percentage change in mean inspiratory flow 







Figure 6.3  Box and whisker plot of the time constant of the response to hypercarbia at 






Figure 6.4  Box and whisker plots of the ventilatory response to hypercarbia by smoking 
(S), substance misuse(SM) and age of study status. Dotted box plots denote neonatal 










6.4 Discussion  
 
 At the peak age for SIDS these results demonstrated that infants of smoking and substance-
misusing/smoking mothers have a dampened ventilatory response to hypercarbia compared to 
controls.  In addition, the ventilatory response to hypercarbia was poorer in the infants of 
substance misusing mothers compared to those of smoking mothers.  There was also a lower 
increase in central respiratory drive, as indicated by a lower mean inspiratory flow (MIF) and 
a delayed response to hypercarbia, that is a longer time constant (Tc) in infants of smoking 
and substance-misusing/smoking mothers.  The results also indicate a decline in carbon 
dioxide sensitivity from the neonatal period to the peak age for SIDS.  To my knowledge, this 
is the first study that has compared responses to hypercarbia between infants of smoking and 
substance misusing mothers and controls and examined changes in carbon dioxide sensitivity 
in such infants with increasing age.  The results showing a reduction in chemosensitivity at 
the peak age for SIDS compared to the neonatal period are consistent with previous findings 
showing the rate of response to added deadspace was significantly dampened with increasing 
postnatal age (Saiki et al., 2011).  
 
Infants exposed to methadone in utero have been demonstrated to have a decreased 
sensitivity to a carbon dioxide challenge, that is a lower slope of the ventilatory response 
curve to CO2 during the first weeks after birth (Olsen and Lees, 1980). Similarly in infants of 
substance misusing mothers compared to controls, had lower increased in tidal volume and 
minute ventilation on exposure to 4% CO2 in the newborn period (Wingkun et al., 1995). At 
nine weeks of age, infants of substance misusing mothers were shown to take longer to 
arouse a hypercapnic challenge (Ward et al., 1992).  
Infants of smoking mothers in the newborn period have been shown to have a dampened 
response to added dead space; the main stimulus during “tube” breathing is hypercarbia (Bhat 
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et al., 2005). In contrasts, infants of smoking mothers studied at one to three months of age 
did not have a reduced ventilatory response compared to controls(Campbell et al., 2001) . In 
that study, however, infants were exposed simultaneously to both hypoxia and 
hypercarbia(Campbell et al., 2001). 
 
Serotonin (5 hydroxytryptamine, 5-HT) neurons play a key role central chemoreception 
(Richerson, 2004). Prenatal exposures to alcohol and cigarette smoke are associated with 
harmful effects on the development of the human medullary 5-HT system (Kinney, 2009). 
Exposure to maternal smoking and cocaine cause upregulation of the 5 HT transporter 
(5HTT) which is the key regulator of the 5HT levels at the synapse (Awtry and Werling, 
2003, Bauman et al., 2000) (Kelai et al., 2003).  Prenatal-perinatal exposure to nicotine alters 
the activity, electrical properties and central chemosensitivity of the raphe obscurus neurones 
(Cerpa et al., 2015). 
 
There are strengths and some limitations to the study.  The infants’ responses to a series of 
CO2 challenges were assessed; the order in which the levels were studied was randomised.  In 
all three groups, an increase in the ventilatory response to increasing CO2 was seen.  
Longitudinal data were obtained on 44 infants and the paired analysis demonstrated a 
significantly lower ventilatory response to CO2 at the peak age for SIDS.   It was not possible 
to assess at follow up all those infants studied in the neonatal period, but there were no 
significant differences in the demographics of those followed and not followed.  Substance 
misuse and smoking status were confirmed by urinary analyses in the immediate neonatal 
period.   It was not possible to assess the impact of substance misuse alone as all substance- 
misusing mothers also smoked.  The significant differences in the responses of the SM 
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infants and the S infants, however, suggest that substance misuse and smoking have an 
additive adverse effect. 
 
In conclusion, infants of smoking and substance misusing/smoking mothers compared to 
controls had a reduced response to a hypercarbic challenge at the peak age for SIDS, the 
infants of substance misusing /smoking mothers having the lowest response.  These results 
are compatible with dampened chemoreceptor function in infants exposed to smoking and 
substance misuse.  The response was lower at 6-12 weeks than in the neonatal period and 
























7 Responses to hypoxia in infants of smoking and 

















7.1 Introduction  
 
Maternal smoking is associated with at least a three-fold increased risk of SIDS (Mitchell and 
Milerad, 2006) . Maternal misuse of cocaine (Durand et al., 1990) and opiates (Ward et al., 
1990) (Burns et al., 2010) have been shown to increase the risk of SIDS.  
SIDS has been hypothesised to be due to brainstem abnormalities that could adversely affect 
ventilatory control. Studies in the neonatal period (chapter 5), showed that newborns of 
smoking and substance-abusing mothers had an impaired ventilatory response to hypoxic 
challenge. Infants of SM mothers had a greater magnitude of decline in ventilation than the 
controls and S infants and both the SM and S infants had a greater rate of decline in minute 
ventilation compared to controls (chapter 5). 
The aim of this study was to test the hypothesis that infants of substance misusing mothers or 
smoking mothers would have a poorer ventilatory response to hypoxia compared to infants of 
non-substance-misusing, non-smoking mothers at the peak age of SIDS. In addition, I 
hypothesized that smoking and substance misuse would have an additive effect, and hence 
any impairment of the ventilatory response to hypoxia would be greater in infants of mothers 
who both substance misused and smoked.  A further aim of this study was to determine if any 
differences between the S, SM and control groups differed at 6-12 weeks compared to the 






7.2 Methods  
 
Infants were eligible for entry into the study if they were born at 36 weeks of gestational age 
or greater at King’s College Hospital NHS Foundation Trust and had been assessed in the 
neonatal period prior to maternity unit discharge. Informed written parental consent was 
obtained and the study was approved by the Guy’s and St Thomas’s Hospitals NHS 
Foundation Trust Research Ethics Committee. 
Three groups were recruited: 
1. Infants of mothers who gave on antenatal screening a history of substance misuse 
during pregnancy (SM infants). 
2. Infants of mothers who gave a history of smoking during pregnancy and the 
postpartum period (S infants).  
3. Infants of mothers who neither smoked nor misused substances during pregnancy and 
the postpartum period (controls). 
 
7.2.1 Hypoxic challenge  
 
The hypoxic challenge was delivered via a facemask and custom-made open circuit system 
using 15% oxygen in balanced nitrogen (BOC Gases, UK) as described in chapter 2. 
The responses to the hypoxic challenge were determined by:   
1) The magnitude of increase in minute ventilation from baseline to the peak ventilation 
2) The magnitude of decline in minute volume from the peak to the lowest minute volume  




4) Magnitude of increase in heart rate from baseline to peak in response to hypoxic challenge  
5) Changes in end tidal CO2 (ETCO2) with hypoxia  
The time to peak minute ventilation was noted, as was the time to the lowest SaO2. 
7.2.2 Statistical analysis  
 
The data were tested using the Kolmogorov-Smirnov test and found to be not normally 
distributed. Differences between in the three groups were assessed for statistical significance 
using the Kruskal-Wallis one-way analysis of variance for continuous variables and Chi-
square for categorical variables. Differences between results in the neonatal period and at 6-
12 weeks post term were assessed for statistical significance using the paired Wilcoxon rank 
sum test. Analysis was performed using SPSS version 22.0 (SPSS, Inc., Chicago, IL). 
7.2.3 Sample size 
  
We recruited 61 infants (21 SM, 21 S and 19 controls) in the neonatal period.  That sample 
size allowed detection of a difference equivalent to one standard deviation in each outcome 
between the three groups with 80% power at the 5% level. A similar magnitude of difference 
had been detected in the ventilatory response to added dead space between newborns of 











Thirty-five of the 61 infants were recruited in the neonatal period completed the follow up 
studies at 6-12 weeks of age. There were no significant differences in gestational age, birth 
weight, gender, mode of delivery or maternal age between those who did and did not 
complete the follow up studies (Table 7. 1).  Twelve substance-misuse (SM), 12 smoking (S) 
and 11 control infants were assessed at 6-12 weeks of age (Table 7.2). There were no 
significant differences between the groups with regard to the weight, gender, age at the study 
or maternal age. 
The urine analysis in the immediate postpartum period demonstrated that all the mothers of 
SM infants were also smoking, but that none of the mothers of the controls were smoking. 
The urine analysis also demonstrated that none of the mothers of S infants or the controls had 
been substance misusing.  In the SM group, urine analysis in the immediate postpartum 
period demonstrated seven women were on methadone, two had misused cocaine and three 
had misused multiple drugs. 
There was no significant difference between the groups in baseline minute volume (p=0.17) 
(Table 7.3).  The initial increase in minute volume during the hypoxic challenge did not differ 
significantly between the groups (p=0.309) (Table 7.3). There were no significant differences 
in the time to peak minute ventilation between the groups (p=0.056). The magnitude of the 
subsequent decline in minute volume varied significantly between the groups (p=0.02) with a 
greater magnitude of decline occurring in the S (p=0.037) and the SM infants (p=0.016) 
compared to controls (Table7. 3) (Figure7. 1).  The baseline ETCO2, the ETCO2 decline and 
the ETCO2 increase with hypoxic ventilatory decline did not differ significantly between the 
groups (Table 7.3). 
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There were no significant differences in the baseline oxygen saturation or baseline heart rate 
between the groups (Table 7. 4).  The percentage decline in oxygen saturation was 
significantly different between the groups (p= 0.031). The time to the lowest oxygen 
saturation was greater in the controls than the infants of S (p= 0.036) or SM (p= 0.014) 
mothers (Table 7.4). There was a significantly higher increase in heart rate with the hypoxic 
challenge in the controls compared to S (p= 0.05) and SM (p= 0.01) infants.  
Comparison of the results in the neonatal period and at 6-12 weeks of age showed that the 
baseline minute volume was significantly higher in the neonatal period (p=0.009). There were 
no significant differences in the magnitude of the increase in ventilation between the two 
study periods, but the magnitude of decline was significantly higher in the neonatal period 













Table 7.1 Comparison of the infant demographics and maternal age between those who 
did and did not complete the follow up study 




No follow up (n=26) P value  
 







Birth weight (gm) 2850 (1730-
4970) 
3092 (1860-4460) 0.08 
Gender (male) 21 (60%)  16 (61.5%) 0.126 
Mode of delivery (SVD) 25(71.4%) 18 (69.2%) 0.640 





Table 7.2 Demographics of the infants who completed the follow up studies by smoking 
and substance misuse status 
N Control (11) S (12) SM (12) P value  
Weight (kg) 4.5 (3.66-6.68) 4.5 (4-6.5) 4.36 (3.5-5.6) 0.474 
Gender (male) 7 (63.6%) 8 (66.7%) 5 (41.6%) 0.405 
Age at study (wks) 8 (6-12) 8 (7-10) 8 (6-11) 0.954 





Table 7.3 Changes in minute ventilation and ETCO2 in response to hypoxia by 
maternal smoking (S) and substance-misuse status 
 Control (n=11) S (n=12) SM (n=12) P value 
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Table 7.4   Changes in oxygen saturation (SaO2) and heart rate with hypoxic challenge 
by maternal smoking and substance misuse status 
 Control (n=11) S (n=12) SM (n=12) P value 
Baseline SaO2 (%) 100 (97-100) 100 (94-100) 99 (97-100) 0.719 

































Increase in heart rate 












Table 7.5 Ventilatory response to hypoxia in the neonatal period and 6-12 weeks 
 Neonatal (n=61) 6-12 weeks (n=35) P value 
Baseline minute volume 
(ml/kg/min) 
344 (203-614) 300 (200-475) 0.009 
Increase in minute volume 
(ml/kg/min) 
47 (0-374) 55 (0-200) 0.221 















Figure 7.1 Box and whisker plot of the magnitude of decline in minute volume by 
















Figure 7.2 Box plot magnitude of hypoxic decline in minute ventilation with hypoxia in 










7.4 Discussion  
 
 At the peak age of SIDS infants of SM and S mothers had a greater magnitude of decline in 
ventilation in response to a hypoxic challenge compared with controls.  Importantly, maternal 
substance misuse and smoking had an additive adverse effect on the response.  There was a 
greater percentage decline in oxygen saturation in response to hypoxia in the SM and S 
infants compared to controls. In addition, the SM and S infants reached the lowest saturation 
level earlier in the course of the hypoxic challenge.   These effects were greater in the SM 
infants.  Previous studies have highlighted that maternal smoking or substance-misuse 
impairs the infant ventilatory and arousal responses to a hypoxic challenge out with the 
neonatal period (Lewis and Bosque, 1995, Ueda et al., 1999). Infants of smoking mothers had 
a blunted response to a hypoxic stimulus (Ueda et al., 1999, Ward et al., 1992) at 24 months 
of age.  Similarly, at two to three months of age, infants of smoking mothers compared to 
controls had impaired arousal responses in response to a hypoxic challenge (Lewis and 
Bosque, 1995).  Furthermore, a smaller fall in end-tidal carbon dioxide and impaired arousal 
responses in response to a hypoxic challenge in infants of substance-abusing mothers at nine 
weeks of age has been demonstrated(Ward et al., 1992)   
The increase in heart rate in response to hypoxia was greater in the controls than the SM or S 
infants.  The ventilatory response to hypoxia increases lung stretch receptor activity via 
cardiac vagal motoneurons resulting in tachycardia (Dawes et al., 1968, Marshall, 1994, Daly 
and Kirkman, 1989, Daly et al., 1978). In term born infants aged 2-82 days, maternal 
smoking affected the magnitude and the time course of heart rate increase in response to 
hypoxia compared to controls(Sovik et al., 2001). The effect of maternal substance misuse on 




One study reported that the biphasic response had disappeared by ten days of age (Brady and 
Ceruti, 1966), while others have reported that the immature biphasic response to hypoxia 
persisted into the second month of postnatal life in both prematurely born (Martin et al., 
1998) and term born infants(Cohen et al., 1997). Another study showed that the biphasic 
response to hypoxia persisted in both quiet and active sleep at five to six months of 
age(Richardson et al., 2007). Our results confirm the persistence of the biphasic response to 
hypoxia at 6-12 weeks. The magnitude of decline in minute volume in response to hypoxia 
was less marked at 6-12 weeks of age compared to the neonatal period, reflecting a 
maturational effect.    
The study has strengths and some limitations.   The ventilatory response to hypoxia was 
assessed in three groups whose status was confirmed by urinary analysis in the immediate 
post-partum period. Although, only approximately half of those recruited in the neonatal 
period were followed, there were no significant differences in the demographics of those who 
were and were not followed-up. To my knowledge this is the first study which has compared 
the responses to hypoxia in infants of SM/S mothers and S mothers both at the peak age for 
SIDS and in the early neonatal period. 
In conclusion, I have demonstrated a change in the ventilatory response to a hypoxic 
challenge over the first months after birth.  Nevertheless, at the peak age for SIDS, there was 
a greater decline in minute ventilation in response to hypoxia in the infants of smoking 
mothers and substance misusing mothers and, in particular the infants of substance misusing 










































The main findings of this thesis are: 
 
 In chapter three, I have shown that there was no correlation between self-reported 
maternal smoking and maternal urine cotinine levels obtained in the perinatal period. 
 
 In chapter four, I have shown that infants of both smoking and substance-
misusing/smoking mothers compared to controls had a dampened response to a 
hypercarbic challenge in the perinatal period. The infants of mothers who substance 
abused and smoked during pregnancy had a more dampened response than the infants 
of mothers who only smoked. 
 
 
 In chapter five, I demonstrated that infants of SM/S mothers had a greater magnitude 
of decline in ventilation in response to hypoxic challenge than the S infants or the 
controls in the newborn period suggesting that substance misuse and smoking may 
have an additive effect. I also demonstrated that SM and S infants compared to 
controls had a greater rate of decline in ventilation in response to a hypoxic challenge 
in the newborn period. 
 
 In chapter six, I have shown that infants of smoking and substance misusing/smoking 
mothers compared to controls had a reduced response to a hypercarbic challenge at 
the peak age for SIDS, the infants of substance misusing /smoking mothers having 
the lowest response. I also demonstrated that the ventilatory response to hypercarbia 




 In chapter seven, I have shown that at the peak age for SIDS, there was a greater 
decline in minute ventilation in response to hypoxia in the infants of smoking mothers 
and substance misusing mothers and, in particular the infants of substance misusing 
/smoking mothers. I have also shown that there was less decline in minute ventilation 
in response to hypoxic challenge with increasing postnatal age indicating  a 




















8.2 Strengths and limitations of the studies:  
 
Maternal reports of smoking and substance misuse practices were not relied on to categorise 
which group an infant belonged, the mothers’ and infants’ urine samples were analysed 
postnatally for cotinine and illicit drugs. Urine samples from mothers and infants in the 
control group were negative for cotinine and illicit drugs. All mothers in the SM group tested 
positive for one of five illicit drugs included in the urinary drug screen; with the majority 
testing positive for more than one drug. In addition, all of the mothers in the SM group also 
smoked, their urine samples were positive for cotinine. There was no correlation between 
maternal self-reported number of cigarettes smoked/day and maternal urine cotinine level.  
Self-reports of smoking and cotinine levels did not differ between infants and mothers in the 
SM and S groups and between mothers who both tobacco and cannabis smoked compared to 
mothers who tobacco smoked only. Recent studies assessing the level of agreement between 
self-reporting of smoking and cotinine have provided conflicting results.   Although, some 
showed a high level of agreement between self-reports and cotinine levels (Mattsson et al., 
2016), others did not (Dietz et al., 2011).  
The neonatal ventilatory responses to hypercarbia were assessed using a steady state CO2 
inhalation method. This method rather than the added dead space was chosen as it provided a 
pure hypercarbic challenge rather than the mixed hypercarbic/hypoxic challenge with the 
added dead space method (Upton et al., 1990). The response to the hypercarbic challenge in 
the newborn period was assessed between the three groups in a number of ways which 
demonstrated consistent findings.  There were significant differences in baseline 
characteristics, but the results remained statistically significant after adjusting for those 
baseline differences. At baseline, the SM and S infants differed with regard to minute 
volume. Despite the differences in minute volume at baseline, significant differences in the 
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response to increasing levels of CO2 were demonstrated between the three groups. To my 
knowledge, this is the first study that has compared the responses to hypercarbia in infants of 
substance-misuse/smoking mothers and infants of smoking mothers. Newborns were studied 
prior to maternity unit discharge, thus the findings of impaired ventilatory response to 
hypercarbia demonstrated in this thesis reflects the effects of antenatal smoking and 
substance-misuse. I was unable to study the effects of maternal substance misuse separately 
as all the SM mothers also smoked. In addition, I was also unable to study the effects of 
specific drugs on neonatal ventilatory response to hypercarbia because majority of the SM 
mothers misused multiple drugs.  
The newborn’s responses to hypoxic challenge were assessed in the three groups of infants 
(SM, S infants and controls) using 15% oxygen in nitrogen. The responses to hypoxia were 
assessed by a variety of outcomes; changes in oxygen saturation both in terms of magnitude 
and time course in response to hypoxia as well as the changes in minute volume at different 
times during the hypoxic challenge. This thesis has demonstrated that infants of SM mothers 
had a greater magnitude of decline in ventilation than controls and S infants and both the SM 
and S infants had a greater rate of decline in minute ventilation compared to controls.  The 
three groups’ gestational ages differed significantly and, as maturity at birth affects 
respiratory control, adjustment was made for differences in gestational age.   Significant 
differences remained after that adjustment.  Infants of SM mothers had a greater initial 
increase in minute ventilation in response to hypoxia compared to S infants and controls. 
Similarly, differences between the three groups remained significant after adjustment for 
gestational age.  Oxygen saturation level did not fall below 85% in all infants; hence I 
compared the time to the lowest oxygen saturation level in the three groups.  The time taken 
to reach the lowest SaO2 was significantly longer in the controls compared to either infants in 
the S or SM groups, likely reflecting the latter two groups had a greater magnitude of decline 
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in ventilation than the controls.  A sidestream method was used to measure ETCO2 levels 
using a CO2 sampling line and capnography. The sidestream method does not adequately 
monitor both nasal and oral airflow. Given the method I used to measure ETCO2, it was not 
possible to accurately evaluate the changes in ETCO2 at different periods during the hypoxic 
challenge. Hence I did not report the ETCO2 levels throughout the challenges. Nevertheless, I 
was able to show a significant difference in the response of the SM infants to the hypoxic 
challenge compared to both the controls and the S infants. To my knowledge, this is the first 
study that has compared the responses to hypoxia in newborns of substance-misuse/smoking 
mothers and smoking mothers. Infants were studied prior to maternity/neonatal unit discharge 
and thus I was able to assess the effects of only the antenatal exposure to smoking and illicit 
substances on ventilatory response to hypoxia.   
 
I studied the ventilatory responses to hypercarbia at 6-12 week of age in 44 of the 78 infants 
studied in the neonatal period. Nevertheless, there were no differences in the demographics 
between those who did and did not complete the follow up studies. Infants of S and SM 
mothers have a dampened ventilatory response to hypercarbia compared to controls at the 
peak age for SIDS.  In addition, the ventilatory response to hypercarbia was poorer in the 
infants of SM mothers compared to those of S mothers. The impaired ventilatory response to 
hypercarbia in SM and S infants at the peak age for SIDS was demonstrated in different 
ways; SM and S infants had a lower slope of ventilatory response to hypercarbia, lower 
magnitude of increase in central respiratory drive in response to hypercarbia and a delay in 
time response to the hypercarbic challenge compared to controls. I have also demonstrated a 
decline in CO2 sensitivity at the peak age for SIDS compared to the neonatal period.  There is 
limited longitudinal data on the changes of chemoreceptor responses with increasing 
postnatal age. In prematurely born infants studied at PMA of 45 weeks gestation, the rate of 
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response to added dead space significantly delayed in prone compared to supine position 
(Saiki et al., 2011).  
 
Responses to hypoxic challenge at the peak age for SIDS demonstrated that infants of SM 
and S mothers had a greater magnitude of decline in ventilation in response to a hypoxic 
challenge compared with controls.  Importantly, maternal substance misuse and smoking had 
an additive adverse effect on the response.  There was a greater percentage decline in oxygen 
saturation in response to hypoxia in the SM and S infants compared to controls. In addition, 
the SM and S infants reached the lowest saturation level earlier in the course of the hypoxic 
challenge. In response to hypoxic challenge there was a greater increase in heart rate in 
controls compared to S and SM infants. The effects of maternal substance-misuse on 
cardiovascular responses to hypoxic challenge have not been previously described. These 
effects were greater in the SM infants. Comparison of the results of the hypoxic challenge 
between the neonatal period and 6-12 weeks of age showed that there was a lesser decline in 
ventilation in response to hypoxia with advancing postnatal age likely reflecting maturation 
of the hypoxic ventilatory response. There were no differences between the two age groups in 
the magnitude of initial increase in minute volume in response to hypoxia. Although, only 
approximately half of those recruited in the neonatal period were followed, there were no 
significant differences in the demographics of those who were and were not followed-up. To 
my knowledge this is the first study which has compared the responses to hypoxia in infants 
of SM/S mothers and S mothers both at the peak age for SIDS and examined changes in 
ventilatory response to hypoxia SM, S infants and controls with increasing postnatal age.  
The hypoxic and hypercarbic challenges were performed during quiet sleep as indicated by 
observational assessment i.e. when breathing was regular and with less frequent arousals. 
This meant that the potential influences of arousal on the ventilatory responses to the 
156 
 
challenges could not be taken into consideration. The hypoxic ventilatory response is 
dependent on the vigilance state (Henderson-Smart and Cohen, 1988) (Henderson-Smart and 
Read, 1979) (Lovering et al., 2003, Richardson et al., 2007, Rigatto, 1984, Stephenson et al., 
2001). In newborn lambs, active compared to quiet sleep was associated with ribcage 
deflation during inspiration, a depressed ventilatory response to hypoxaemia despite increases 
in respiratory rate and delayed arousal (Henderson-Smart and Read, 1979). Similarly, the 
ventilatory response to hypoxia in adult cats was least in rapid eye movement sleep. 
(Lovering et al., 2003, Richardson et al., 2007, Rigatto, 1984) A study of male Sprague-
Dawley rats demonstrated that ventilation measured by plethysmography was significantly 
greater during wakefulness than either NREM or REM sleep and ventilation significantly 
decreased from wakefulness to NREM sleep to REM sleep (Stephenson et al., 2001) 
 There is conflicting evidence regarding the influence of sleep stage on the ventilatory 
response to hypercapnia. A difference in resting ventilation and in the response to CO2 when 
REM and NREM sleep episodes were compared was not apparent in newborn monkeys less 
than three weeks of age (Guthrie et al., 1980), nor was it apparent in premature infants 
(Kalapesi et al., 1981, Rigatto et al., 1980) or term infants until about three months of age 
(Haddad et al., 1980) . A small increase in ventilation during REM sleep, however, was noted 
in l l-week-old healthy infants compared to siblings of SIDS victims and infants with a 
history of apnea (Fagenholz et al., 1976). Although, limiting the studies in this thesis to quiet 
sleep, may have limited the potential applicability of the studies findings, it would not have 
influenced the differences detected in ventilatory responses to hypoxia and hypercarbia 
between the groups. 
There is evidence that changes in body temperature alter the ventilatory responses to hypoxia 
and hypercarbia (Bonora and Gautier, 1989, Cunningham and O'Riordan, 1957, Jennings and 
Laupacis, 1982, Maskrey and Jennings, 1985) (Maskrey and Nicol, 1979, Vejby-Christensen 
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and Strange Petersen, 1973). Cats exposed to thermal load had an enhanced ventilatory 
response to hypoxia (Bonora and Gautier, 1989) and resting, awake dogs had a reduced 
ventilatory response to CO2  at lower body temperatures (Jennings and Laupacis, 1982). The 
environmental temperature at which the studies were undertaken in my thesis were performed 
was not standardised. Nevertheless, studies in the neonatal period and at 6 to12 weeks of age 
were carried out in the same environment; therefore, it seems likely that similar temperatures 
were used when assessing the ventilatory responses to hypercarbia and hypoxia between the 
groups. 
The hypercarbic and hypoxic challenges were performed in the neonatal period and at 6 to12 
weeks of age using a facemask. There is evidence that the use of a facemask may disturb the 
normal pattern of respiration. Flemming et al (Fleming et al., 1982) showed that the 
application of a facemask in term infants, studied at one to four days of age, resulted in a fall 
in the respiratory rate and a rise in tidal volume in both QS and REM sleep. The authors 
suggested that the changes in respiratory pattern may have been produced by stimulation of 
receptors in the trigeminal area (Fleming et al., 1982). Such trigeminal stimulation gives rise 
to cardiorespiratory reflexes in many newborn animals (Haddad and Mellins, 1977). Others 
have also shown hypoventilation on  face mask application in preterm infants (Chernick and 
Avery, 1966) and  adults (Askanazi et al., 1980). Such changes could also be caused by an 
increase in airway resistance due to partial airway obstruction (Doershuk et al., 1970). A 
facemask was used throughout during the hypercarbic and hypoxic challenge in all three 
groups of infants. Hence, it is unlikely use of a facemask would have influenced the 




8.3 Subsequent research findings: 
The results of this thesis have demonstrated effects of antenatal smoking and substance-
misuse on newborn’s and 6-12 weeks aged infant’s chemoreceptor responses and highlighted 
a possible mechanism in the causation of SIDS. Newborns and 6-12 weeks old infants of 
smoking and substance-abusing mothers had dampened chemoreceptor responses to 
hypercarbia and hypoxia in both age groups compared to controls.  
SIDS is still the leading cause of post-neonatal infant death in the USA(Kinney and Thach, 
2009) . Maternal cigarette smoking during pregnancy is the leading risk factor for SIDS. A 
recent meta-analysis by (Zhang and Wang, 2013) showed that both prenatal and postnatal 
maternal smoking, were associated with a significantly increased risk of SIDS (OR = 2.25, 
95% CI = 2.03–2.50 for prenatal maternal smoking, and OR = 1.97, 95% CI = 1.77–2.19 for 
postnatal maternal smoking, respectively). In the United-States, although the prevalence of 
illicit drug use among pregnant women does not appear to have changed since the early 
2000s, (Kellogg et al., 2011) the types of drugs that pregnant women are using may have 
shifted. Chronic medical use of prescription narcotics during pregnancy increased 
significantly from approximately 2.5 per 1,000 deliveries in 2000 to over 10.0 per 1,000 
deliveries in 2008. (Kellogg et al., 2011). This is consistent with the documented increase in 
therapeutic and nonmedical use of prescription pain relievers in the United States.(Okie, 
2010, Manchikanti et al., 2010). A recent large national cohort of nearly 300 centres in the 
United States, found increases from 2004 through to 2013 in patient admissions, length of 
stay and resource utilization for infants admitted to NICUs with the neonatal abstinence 
syndrome (Tolia et al., 2015). 
Recent neuropathologic SIDS research focused upon the role of brain regions, particularly the 
brainstem, that regulate or modulate autonomic and respiratory control during sleep or 
transitions to waking. The arcuate nucleus is a structure located on the ventral medullary 
159 
 
surface and is thought to be responsible for integration for autonomic, ventilatory and arousal 
response in addition to having a role in generating a central response to hypercarbia (Kinney 
et al., 1992); (Kinney et al., 1995). This nucleus has been reported to be hypoplastic and 
hypomyelinated in SIDS cases (Filiano and Kinney, 1992b); (Lavezzi et al., 2004); (Matturri 
et al., 2005);  (Biondo et al., 2003). In addition, in approximately 50-70% of infants with 
SIDS, abnormalities involving the serotonergic system have been seen (Paterson et al., 2006); 
(Kinney et al., 2001). Infants who died of SIDS have been shown to have a higher number 
and density of 5 HT neurons and a lower density of 5-HT1A receptor binding sites in the 
regions of medulla involved in cardio-respiratory regulatory function (Paterson et al., 2006). 
This suggests quite extensive abnormalities involving the serotonin system in the brainstem 
in SIDS victims involving the synthesis, release and clearance of 5 HT (Moon et al., 2007a). 
There is emerging evidence that prenatal exposure to maternal cigarette smoking and alcohol 
affects the postnatal development of human brainstem 5-HT pathways which plays a key role 
in central chemoreception (Kinney, 2009).  In a blinded study of hippocampal morphology in 
153 infants with sudden and unexpected death autopsied in the San Diego County medical 
examiner’s office, deaths were classified as unexplained or explained based upon autopsy and 
scene investigation. Focal granule cell bilamination was present in 41.2 % (47/114) of the 
unexplained group compared to 7.7 % (3/39) of the explained (control) group (p < 0.001) 
(Kinney et al., 2015). It was associated with a cluster of other dentate developmental 
abnormalities that reflect defective neuronal proliferation, migration, and/or survival. The 
authors speculated that the dentate lesions in a large subset of infants with sudden 
unexplained death might represent a developmental vulnerability that leads to 
autonomic/respiratory instability and sleep-related death when the infants are challenged with 
homeostatic stressors. Importantly, these lesions can be recognized in microscopic sections 
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prepared in current forensic practice and in the future this could be incorporated into the 
forensic investigations of sudden infant death  (Kinney et al., 2015). 
 Recent animal studies also assessed ventilatory responses to hypoxia following prenatal 
nicotine exposure. Zhuang et al (Zhuang et al., 2014) recently found   that “full term” 
prenatal nicotinic exposure (fPNE) compared to traditional prenatal nicotinic exposure 
(tPNE), triggers the apneic response to hypoxia (5% O2 for 60 min), leading to a lethal 
ventilatory arrest in rat pups. (Zhuang et al., 2014). The author speculated that nicotinic 
exposure at the early stage of gestation is critical in generating the delayed hypoxic 
ventilatory response  and subsequent death occurring independently of brain/pulmonary 
oedema and changes in arterial blood pH/gases (Zhuang et al., 2014) 
A study of prematurely born infants at a median post menstrual age of 45 weeks assessed to 
their response to added dead space in relation to sleeping position however highlighted that 
the rate of their ventilatory response to added dead space was dampened in the prone 
compared to supine position (Saiki et al., 2010). This suggests that premature infants mount a 
poor ventilatory response to an external stress in the prone position and this could possibly 









8.4 Future work: 
 
In this thesis, the effects of maternal smoking and substance misuse on the chemoreceptor 
responses were studied in the neonatal period and at the peak age for SIDS with studies in 
both age groups performed in the supine position. Indeed, there is evidence that the risk of 
SIDS with maternal smoking increases significantly if infants slept in prone position. It will 
therefore, be valuable to study the combined effects of smoking, substance-misuse and 
sleeping position in chemoreceptor responses both in the newborn period and at the peak age 
for SIDS. 
Impaired arousal responses to hypoxia and hypercarbia have been hypothesized as important 
pre terminal events prior to SIDS. Indeed, impaired arousal responses to hypoxia/hypercarbia 
have been demonstrated in SM infants at the peak age for SIDS (Ward et al., 1992) Similarly, 
infants of smoking mothers have been shown to have a deficient arousal response to hypoxic 
challenge at two to three months of age (Lewis and Bosque, 1995).  Another important future 
research study would be to undertake studies in newborns and infants of smoking and 
substance abusing mothers to assess arousal responses to hypoxia and hypercarbia both in the 
newborn period and the peak age for SIDS. Serial studies  would not only provide valuable 
information regarding possible mechanisms of SIDS in S and SM infants, but also whether a 
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